I010: Potentially high prevalence of primary aldosteronism in a general practice population in Tayside, Scotland. (Englisch)

in American journal of hypertension ; 12 , S4 ; 204A-a-
American journal of hypertension
Wie erhalte ich diesen Titel?
Download
Kommerziell Vergütung an den Verlag: 30,43 € Grundgebühr: 4,00 € Gesamtpreis: 34,43 €
Akademisch Vergütung an den Verlag: 30,43 € Grundgebühr: 2,00 € Gesamtpreis: 32,43 €

Dokumentinformationen


Inhaltsverzeichnis – Band 12, Ausgabe S4

Zeige alle Jahrgänge und Ausgaben

Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Nachweisen der enthaltenen Aufsätze. Die Anzeige der Jahrgänge kann aufgrund fehlender Aufsatznachweise unvollständig oder lückenhaft sein, obwohl die Zeitschrift komplett in der TIB verfügbar ist.

1A
Cardiac microvascular changes in DOCA-salt hypertensive rats: effect of endothelin ETA receptor antagonism
Larouche, I. / Schiffrin, E.L. | 1999
1A-a
The effects of insulin on renin-angiotensin expression in human cultured vascular endothelial cells
Kamide, K. / Hori, M.T. / Barrett, J.D. / Eggena, P. / Tuck, M.L. | 1999
1A-b
Endothelin and cardiac natriuretic peptides in heart failure
Del Ry, S. / Andreassi, M.G. / Nardini, V. / Colombo, M.G. / Clerico, A. / Biagini, A. / Giannessi, D. | 1999
1A-c
Estrogen stimulates neuronal nitric oxide synthase protein expression in human neutrophils
de Frutos, T. / García-Durán, M. / Díaz-Recasens, J. / Gálvez, G. / Sánchez de Miguel, L. / Montón, M. / Rico, L. / Farré, J. / Romero, J. / Casado, S. et al. | 1999
2A
Ang II-stimulated generation of reactive oxygen species in human vascular smooth muscle cells is mediated via PLD-dependent pathways
Touyz, R.M. / Schiffrin, E.L. | 1999
3A
Aggressive blood pressure control may eliminate racial disparity in hypertensive renal disease: the hypertension optimal treatment trial (hot study)
Jamerson, K. / Ojo, A. / Fierro, G. / Hall, D. / Lawton, W. / Rahman, N. / Ram, V. / Randall, O. / Shultz, P. / Steigerwalt, S. et al. | 1999
3A-a
Misoprostol effects on NSAID-induced cardiorenal changes (MEDIC study)
Munger, M.A. / Gardner, S.F. / Rabetoy, G.M. / Cheung, A.K. / Barri, Y.M. / MEDIC Study Investigators, | 1999
3A-b
Indomethacin increases BP in hypertensive patients controlled with an ace inhibitor
Morgan, T. / Anderson, A. / Bertram, D. / Jones, E. | 1999
3A-c
Rapid recovery of acute vasoconstrictor effect but delayed recovery of full hypertensive effect after single dose losartan in Ang II-infused conscious rats
Sealey, J.E. / Hu, L. / Catanzaro, D.F. / Laragh, J.H. | 1999
4A
Abnormal renal and humoral response to sodium in hypertensive patients with the CC-genotype of the angiotensin II type 1 receptor
Spiering, W. / Kroon, A.A. / Fuss-Lejeune, M.J.M.J. / Daemen, M.J.A.P. / de Leeuw, P.W. | 1999
4A-a
Relationship of angiotensin converting enzyme (ACE) gene polymorphism and salt-sensitivity in essential hypertension
Giner, V. / Poch, E. / Oriola, J. / Bragulat, E. / Gómez-Angelats, E. / Antonio, M.T. / Botey, A. / Coca, A. / de la Sierra, A. | 1999
4A-b
M235T polymorphism of the angiotensinogen gene and cardiovascular-renal risk
Kuznetsova, T. / Wang, J. / Emelianov, D. / Fagard, R. / Vlietinck, R. / Staessen, J.A. | 1999
4A-c
Angiotensinogen genotype affects HDL levels in afro-caribbeans
Robinson, M.T. / Grim, C.E. / Wilson, T.W. / Viswanathan, A. / Lifton, R.P. / Etienne, C. / Grell, G. / Grim, C.M. / Wilson, D.M. / Svahn, D.S. | 1999
5A
The maternal inheritance of hypertension among African Americans
Chung, A.B. / Doyle, J.P. / Wallace, D.C. / Hall, W.D. | 1999
5A-a
T344C aldosterone synthase gene polymorphism in low renin hypertension
Regolisti, G. / Rossi, E. / Casali, B. / Perazzoli, F. / Nicoli, D. / Negro, A. / Davoli, S. / Sani, C. / Farnetti, E. | 1999
6A
Genetic polymorphism of the renin-angiotensin-aldosterone system (RAAS) and organ damage (TOD) in essential hypertension (EH)
Pontremoli, R. / Viazzi, F. / Nicolella, C. / Ravera, M. / Berruti, V. / Leoncini, G. / Bezante, G.P. / Zagami, P. / Ravazzolo, R. / Deferrari, G. | 1999
6A-a
Parallelism between cardiac and vascular changes at different sites in the early phase of hypertension
Vaudo, G. / Schillaci, G. / Evangelista, F. / Pasqualini, L. / Verdecchia, P. / Mannarino, E. | 1999
6A-b
Determinants of left ventricular mass in French middle-aged male population
Thomas, F. / Benetos, A. / Ducimetière, P. / Guize, L. | 1999
6A-c
Hemodynamics of resistant hypertension in the current era
Taler, S.J. / Augustine, J. / Schwartz, L. / Textor, S.C. | 1999
7A
Abnormal prothrombotic factors and endothelial dysfunction in isolated systolic hypertension: implications for thrombogenesis and atherogenesis
Lip, GYH. / Blann, A.D. / Jones, A.F. / Beevers, D.G. | 1999
7A-a
p53 is not involved in the overexpression of bax protein in the left ventricle of SHR
Fortuño, M.A. / Zalba, G. / Fortuño, A. / Ravassa, S. / D'Lom, E. / Díez, J. | 1999
7A-b
Impaired synthesis of elastin during fetal and infant life as a cause of raised adult blood pressure
Martyn, C.N. / Greenwald, S.E. / Phillips, N. | 1999
7A-c
Defective suppression of aldosterone biosynthesis during stroke permissive diet in the stroke-prone SHR
Gigante, B. / De Paolis, P. / Porcellini, A. / Mele, A.F. / Savoia, C. / Russo, R. / Giliberti, R. / Enea, I. / Rubattu, S. / Ganten, D. et al. | 1999
8A
Elevated potassium concentration inhibits vascular smooth muscle cell proliferation in vitro
Ma, G. / Young, D.B. | 1999
8A-a
Eicosapentaenoic acid is a potent inhibitor of angiotensin II-induced calcium signals in vascular smooth muscle cells
Ormsby, B.L. / Hori, M.T. / Tuck, M.L. | 1999
8A-b
Src modulates Ang II-mediated Ca2+ signaling in human vascular smooth muscle cells
Touyz, R.M. / Wu, X-H. / Schiffrin, E.L. | 1999
8A-c
Tyrosine phosphorylation of human platelet plasma membrane Ca2+-ATPase in hypertension
Blankenship, K.A. / Dawson, C.B. / Aronoff, G.R. / Dean, W.L. | 1999
9A
The role of cyclosporine-A on apoptosis in human vascular smooth muscle cells
Seta, K. / Song, H. / McLaughlin, J.S. / Wei, C. | 1999
10A
Effects of chronic long term calcium-antagonists therapy on cytogenetic damage in humans
Andreassi, M.G. / Varga, A. / Del Ry, S. / Petrozzi, L. / Giannessi, D. / Picano, E. | 1999
10A-a
Importance of gender and age in assessing the 24-hour blood pressure response to antihypertensive therapy
White, W.B. / Johnson, M.F. / Fakouhi, T.D. / Oparil, S. / Sica, D.A. / Black, H.R. | 1999
10A-b
Sildenafil citrate: well-tolerated by patients with erectile dysfunction taking concomitant antihypertensive therapy
Prisant, Michael / Brown, Morris / Sildenafil Study Group, | 1999
10A-c
The ambulatory blood pressure monitoring and treatment of hypertension
Jinxiang, Xie / Lisheng, Liu / APTH Trial Group, | 1999
11A
Major cardiovascular events in long-term treated essential hypertensive patients: Calcium channel blockers (CCB) versus ACE inhibitors (ACEI)
Campo, C. / Segura, J. / Puras, A. / Alcázar, J.M. / Rodicio, J.L. / Ruilope, L.M. | 1999
12A
Combined effect of pulse pressure and heart rate on cardiovascular risk
Thomas, F. / Bean, K. / Morcet, J.F. / Dubanchet, A. / Guize, L. / Benetos, A. | 1999
12A-a
Pulse pressure is an independent predictor of microalbuminuria in non diabetic males
Pedrinelli, R. / Di Bello, V. / Dell'Omo, G. / Giorgi, D. / Bandinelli, S. / Penno, G. / Mariani, M. | 1999
12A-b
Pulse pressure - not mean pressure - determines cardiovascular risk in older hypertensive patients
Gasowski, J. / Blacher, J. / Staessen, J.A. / Girerd, X. / Thijs, L. / Liu, L. / Wang, J.G. / Fagard, R.H. / Safar, M.E. | 1999
12A-c
Pulse pressure: a predictor of cardiovascular mortality among young normotensive subjects
Fang, J. / Madhavan, S. / Alderman, M.H. | 1999
13A
Elevated serum uric acid levels are associated with increased hypertension morbidity in the minority population
San Diego, R. / Pan, D. / Morisky, D. / Enenmoh, A. / Fong, R. / Ward, H. | 1999
13A-a
Serum uric acid, its change with diuretic use and risk of cardiovascular events in the systolic hypertension in the elderly program (SHEP)
Franse, L.V. / Pahor, M. / Di Bari, M. / Shorr, R.I. / Wan, J.Y. / Somes, G.W. / Applegate, W.B. | 1999
14A
Angiotensin II regulates AT2 subtype receptor promoter activity and expression in rat primary endothelial cell
DePaolis, P. / Gigante, B. / Porcellini, A. / Mele, A. / Giliberti, R. / Lombardi, A. / Rubattu, S. / Volpe, M. | 1999
14A-a
Angiotensin II-Mediated apoptosis and P53 expression in human cardiomyocytes
Lau, P. / Kinjo, M. / Song, H. / Seta, K. / Downing, S.W. / Wei, C. | 1999
14A-b
Dual renin targeting by cre-mediated intercromatid recombination.
Matsusaka, T. / Takaya, J. / Katori, H. / Kon, V. / Fogo, A. / Ichikawa, I. | 1999
14A-c
No effect of beta-blockade on the secondary, heart rate-related increase in blood pressure caused by Ang II infusions in conscious rats
Hu, L. / Catanzaro, D.F. / Laragh, J.H. / Sealey, J.E. | 1999
15A
Selective aldosterone antagonist or adrenalectomy prevents L-name/ang II-induced renal injury in rats.
Rocha, R. / Stier, C.T. / Adler, G.K. / Kifor, I. / Mullen, D. / Williams, G.H. | 1999
16A
Long-term angiotensin AT1 receptor blockade with fonsartan increases lifespan of hypertensive rats
Linz, W. / Schölkens, B.A. / Heitsch, H. / Wiemer, G. | 1999
16A-a
Transfer of the Y chromosome from the brown norway rat into the SHR induces significant decreases in blood pressure.
Qi, N. / Kren, V. / Pravenec, M. / Zidek, V. / Krenova, D. / Kurtz, T.W. | 1999
16A-b
PST 2238 a new antihypertensive compound that modulates renal Na-KATPase in genetic hypertension.
Ferrari, P. / Ferrandi, M. / Torielli, L. / Duzzi, L. / Padoani, G. / Minotti, E. / Melloni, P. / Bianchi, G. | 1999
16A-c
Cardiac hypertrophy in the prague hypertensive rat (PHR) is associated with enhanced JNK2 but not ERK tissue activity
Vogel, V. / Bokemeyer, D. / Lindemann, M. / Schmandt, T. / Heller, J. / Kramer, H.J. | 1999
17A
Value of ambulatory BP versus office BP in predicting left ventricular mass index in untreated African-American hypertensives.
White, W.B. / Uwaifo, G.I. / Mansoor, G.A. / Giacco, S. / Suri, R. | 1999
17A-a
The interactive effect of body size and renin-angiotensin axis on blood pressure response to oral salt loading in normotensive African-Americans.
Holmes, C.B. / Staffileno, B.A. / Hamaty, M. / Dudley, A. / Yunis, C. / Grimm, R.H. / Flack, J.M. | 1999
17A-b
Ethnic differences in left ventricular geometry may be due to higher peripheral resistance and an attenuated nocturnal blood pressure decline in African-Americans.
Hinderliter, Alan L. / Waugh, Robert / Kisslo, Joseph / Sherwood, Andrew | 1999
17A-c
Impaired cognitive function in hypertensive patients with asymptomatic cerebral white matter lesions
Sierra, C. / de la Sierra, A. / Salamero, M. / Mercader, J.M. / Aguilera, M.T. / Antonio, M.T. / Gómez-Angelats, E. / Bragulat, E. / Giner, V. / Coca, A. | 1999
18A
Cerebral blood flow in asymptomatic hypertensive patients according to the presence of cerebral white matter lesions
Sierra, C. / de la Sierra, A. / Chamorro, A. / Mercader, J.M. / González, J. / Gómez-Angelats, E. / Antonio, M.T. / Aguilera, M.T. / Coca, A. | 1999
19A
Hypertension does not significantly alter abnormalities of haemorheology, endothelial dysfunction and thrombogenesis in acute stroke: the West birmingham stroke project.
Lip, G.Y.H. / Blann, A.D. / Farooqi, I.S. / Zarifis, J. / Beevers, D.G. | 1999
19A-a
Preactivated peripheral monocytes in hypertensive patients
Dörffel, Y. / Franz, S. / Scholze, S. / Lätsch, C. / Scholze, J. | 1999
20A
Comparison of insulin resistance, lipids, and body size between children with high and low blood pressure: Results from insulin clamp studies in 357 subjects
Sinaiko, A.R. / Steinberger, J. / Moran, A. / Luepker, R.V. / Prineas, R.J. / Rocchini, A.P. / Jacobs, D.R. | 1999
20A-a
Relationship between changes in indices of alcohol intake and blood pressure in the prevention and treatment of hypertension study (PATHS)
Cushman, W.C. / Bingham, S.F. / Hanna, E. / Cutler, J.A. / Kirk, G.F. / Lakshman, M.R. / Dufour, M. / PATHS Group, | 1999
20A-b
High sodium intake is associated with improved insulin sensitivity in sodium sensitive as compared with sodium resistant hypertension prone men
Melander, O. / Willsteen, G. / Groop, L. / Hulthén, U.L. | 1999
20A-c
Association of end tidal CO2 with rate of change in blood pressure over 20 years
Anderson, D.E. / Eyster, C. | 1999
21A
Prevention of preeclampsia with aspirin is dependant on bleeding time increase
Dumont, A. / Beaufils, M. / Flahaut, A. / Verdy, E. / Uzan, S. | 1999
22A
The effect of angiotensin II on human vascular smooth muscle cell apoptosis
Song, H. / Seta, K. / Wei, C. | 1999
22A-a
Selective induction of BCL-XS is a major determinant of vascular smooth muscle cell apoptosis
Igase, M. / Okura, T. / Kitami, Y. / Fukuoka, T. / Takata, Y. / Nakamura, M. / Hiwada, K. | 1999
22A-b
Angiotensin II activation of Src mediates ERK stimulation in human vascular smooth muscle cells
Wu, X-H / Touyz, R.M. / Schiffrin, E.L. | 1999
22A-c
Role of vasopressin in vascular remodeling of DOCA-salt-treated brattleboro rats.
Intengan, H.D. / Schiffrin, E.L. | 1999
23A
Effect of insulin on bradykinin-induced intracellular calcium mobilization in cultured human endothelial cells.
Takagawa, Y. / Hori, M.T. / Tuck, M.L. | 1999
23A-a
Cyclooxygenase-2 (cox-2) in the thick ascending limb: Regulation and function.
Ferreri, N.R. / An, S. / Cespedes, C. / McGiff, J.C. / Vio, C.P. | 1999
23A-b
Hyperphosphorylation and desensitization of the dopamine D1 receptor in renal proximal tubules in essential hypertension
Sanada, H. / Jose, P.A. / Xu, J. / Yu, P. / Hazen-Martin, D. / Carey, R.M. / Felder, R.A. | 1999
23A-c
Dose-related antihypertensive efficacy of omapatrilat, a vasopeptidase inhibitor, in models of normal and low renin hypertension
Burnett, J.C. / Powell, J.R. / Trippodo, N.C. / Omapatrilat Investigators, | 1999
24A
Intrarenal angiotensin levels in hypertensive rats with reduced renal mass
Mackie, F.E. / Campbell, D.J. / Meyer, T.W. | 1999
24A-a
Angiotensin II (AngII) activates nuclear factor-{kappa}B via AT1 and AT2 receptors in the kidney
Ruiz-Ortega, M. / Lorenzo, O. / Ruperez, M. / Egido, J. | 1999
25A
Self-treatment of hypertension with device-guided breathing exercises: a double-blind, randomized study
Schein, M. / Gavish, B. / Herz, M. / Rosner-Kahana, D. / Naveh, P. / Knishkowy, B. / Zlotnikov, E. / Ben-Zvi, N. / Melmed, R.N. | 1999
25A-a
Effect of supplemental calcium on the antihypertensive effectiveness of nifedipine in hypertensive patients
Lewanczuk, R.Z. / Toal, C.B. / on behalf of the Canadian Investigators., | 1999
25A-b
HeartstylesTM profiles: implications of health lifestyle analysis for improving hypertension control.
Weir, M.R. / Maibach, E.W. / Bakris, G.L. / Black, H.R. / Chawla, P. / Messerli, F.H. / Neutel, J.M. / Weber, M.A. | 1999
25A-c
Purified docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans -- a randomised controlled trial.
Mori, T.A. / Bao, D.Q. / Burke, V. / Puddey, I.B. / Beilin, L.J. | 1999
26A
Prevention of dementia in the systolic hypertension in Europe (Syst-Eur) trial
Forette, F. / Staessen, J.A. / Seux, M.L. / Thijs, L. / on bahalf of the Syst-Eur Investigators, | 1999
26A-a
Calcium antagonists and cardiovascular risk in patients with essential hypertension and non-insulin-dependent diabetes
Verdecchia, P. / Schillaci, G. / Borgioni, C. / Ciucci, A. / Porcellati, C. | 1999
26A-b
Evidence of confounding by indication: prescribing of calcium antagonists
Leader, S. / Roht, L. | 1999
26A-c
Monotherapy treatment success rate of omapatrilat, a vasopeptidase inhibitor, compared with lisinopril and amlodipine in mild to moderate hypertension
Black, H.R. / Chang, P.I. / Reeves, R.A. / Cooper, W. / Pouleur, H. / for Omapatrilat Investigators., | 1999
27A
Once-daily effects of the angiotensin receptor blocker, eprosartan on 24-hour blood pressure in patients with systemic hypertension
White, W.B. / Anis Anwar, Y. / Sica, D.A. / Dubb, J. | 1999
28A
Blood pressure response of hypertensive patients to fenoldopam is augmented in non-dippers
Sunthornyothin, S. / Pool, J.L. / Shepherd, A.M.M. / Taylor, A.A. | 1999
28A-a
The effects of hydrochlorothiazide and losartan on fibrinolytic function in normal subjects
Lottermoser, K. / Hertfelder, H.H. / Vetter, H. / Düsing, R. | 1999
28A-b
Comparison of the efficacy of zofenopril or enalapril in patients with mild to moderate hypertension
Giusti, A. / Bertolotti, M. / Llabres, S. / Carre, A. / Casini, A. | 1999
28A-c
Effect of chronic moxonidine therapy on peripheral sympathetic activity in essential hypertension
Greenwood, J.P. / Scott, E.M. / Mary, D.A.S.G. / Stoker, J.B. | 1999
29A
Autonomic balance is shifted toward increased vagal predominance during verapamil compared with amlodipine in patients with mild to moderate hypertension - the vamphyre study
Lefrandt, J.D. / Urbigkeit, A. / Sevre, K. / Castellano, M. / Hausberg, M. / Fallon, M. / Fluckiger, L. / Heitmann, J. / Rostrup, M. / Agabiti Rosei, E. et al. | 1999
29A-a
Effects of the addition of doxazosin to the anyihypertensive treatment in essential hypertensives with benign prostatic hypertrophy
Martell, N. / Fernández-Pinilla, C. / HBP&BPH, | 1999
29A-b
Randomized, prospective dose-comparability study of amlodipine or nifedipine gits in hypertension
Elliott, W.J. / Chrysant, S.G. / DeAbate, C.A. / Denker, F. / Rosansky, S. / Almas, M. / Nuttall, C. | 1999
30A
Increased renal vasodilatory effect of arachidonic acid in spontaneously hypertensive rats. Role of cytochrome P450 pathway
Pomposiello, S. / McGiff, J.C. | 1999
30A-a
Different effects of calcium channel blockers on renal damage development in the fawn-hooded hypertensive rat
Provoost, A.P / Van Dokkum, R.P.E. | 1999
31A
Conventional and ambulatory blood pressure as predictors of cardiovascular risk in older patients with systolic hypertension
Staessen, J.A. / Thijs, L. / Fagard, R. | 1999
31A-a
Do we undertreat hypertensive smokers. A comparison of 24H-ambulatory blood pressure monitoring.
Buttenschøn, T.L. / Bang, L.E. / Kristensen, K.S. / Svendsen, T.L. | 1999
31A-b
Physical activity as a determinant of diurnal blood pressure variation.
Kario, K. / Pickering, T.G. / Schwartz, J.E. | 1999
31A-c
Marital factors over 3 years influence blood pressure and left ventricular mass in mildly hypertensive patients
Baker, B. / Helmers, K. / Paquette, M. / O'Kelly, B. / Tobe, S. | 1999
32A
Augmentation of renal vasoconstrictor responses to norepinephrine and angiotensinii by leptin.
Osei, S.Y. / Ahima, R.S. / Coletti, C. / Krupinski, J. / Flier, J.S. / Hollenberg, N.K. | 1999
32A-a
Marked resistance of the ability of insulin to decrease wave reflection in the aorta characterizes human obesity
Westerbacka, J. / Vehkavaara, S. / Wilkinson, I. / Cockcroft, J. / Yki-Järvinen, H. | 1999
32A-b
High dietary NaCl intake unmasks a pressor effect of chronic intracerebroventricular administration of leptin.
Correia, M.L.G. / Morgan, D.A. / Sivitz, W.I. / Mark, A.L. / Haynes, W.G. | 1999
32A-c
Obesity, hypertension and weight gain-induced blood pressure elevation.
Masuo, K. / Mikami, H. / Ogihara, T. / Tuck, M.L. | 1999
33A
Impaired left ventricular diastolic function during isometric exercise in hypertensive diabetics with albuminuria despite negative stress test may suggest early subclinical myocardial ischaemia
Salmasi, A-M. / Kirollos, C. / Grenfell, A. / Jepson, E. / Dancy, M. | 1999
34A
Calcineurin inhibition does not prevent pressure-overload left ventricular hypertrophy in rat models.
Zhang, W. / Kowal, R.C. / Rusnak, F. / Sikkink, R.A. / Olson, E.N. / Victor, R.G. | 1999
34A-a
Regression of left ventricular hypertrophy on serial echocardiography in the hypertension optimal treatment study.
Amerena, J. / Zabalgoitia, M. / Rahman, Noor U. / Yarows, S. / Haley, W. / Lucas, C. / Yunis, C. / Krause, L. / Ombao, H. / Valentini, M.C. et al. | 1999
34A-b
24-hour ambulatory blood pressure in patients with ECG determined left ventricular hypertrophy: the life study.
Wiinberg, N. / Bang, L.E. / Wachtell, K. / Olsen, M.H. / Tuxen, C. / Rokkedal, J. / Ibsen, H. / Devereux, R.B. | 1999
34A-c
Is the severity of hypertension related to different cardiac features in patients with left ventricular hypertrophy? The preserve study.
Palmieri, Vittorio / Bella, Jonathan N. / Dahlof, Bjorn / DeQuattro, Vincent / Sharpe, Norman / Fishman, Dawn / Devereux, Richard B. | 1999
35A
Impact of different partition values on prevalences of left ventricular hypertrophy and geometry: The life study
Wachtell, K. / Bella, J.N. / Liebson, P.R. / Gerdts, E. / Dahlöf, B. / Papademetriou, V. / Rokkedal, J. / Devereux, R.B. | 1999
36A
Altered adrenal sensitivity to angiotensin II. In low renin essential hypertension
Fisher, N.D.L. / Hurwitz, S. / Ferri, C. / Jeunmaitre, X. / Hollenberg, N.K. / Williams, G.H. | 1999
36A-a
Differential effects of valsartan (V) and lisinopril (L) on potassium [K+] homeostasis in hypertensive patients with nephropathy
Bakris, G.L. / Siomos, M. / Kasprowicz, S. / Bolton, W.K. / Hebert, L. / Catanzaro, D. / Janssen, I. | 1999
36A-b
Renal hemodynamic and hormonal responses to the angiotensin II antagonist, candesartan: The angiotensin II-renin short feedback loop.
Lansang, M.C. / Osei, S.Y. / Price, D.A. / Fisher, N.D.L. / Hollenberg, N.K. | 1999
37A
Academic detailing to promote hypertension (HTN) clinical practice guidelines.
Siegel, D. / Meier, J.L. / Lopez, J.R. | 1999
37A-a
Safety of sildenafil citrate in men with erectile dysfunction taking multiple antihypertensive agents.
Kloner, Robert / Brown, Morris / Sildenafil Study Group, | 1999
38A
Incidental renal artery stenosis detected during coronary angiography in hypertensive patients.
Textor, Stephen / Rihal, Charanjit / McKusick, Michael / Breen, Jerome / Robins, Catriona / Grill, Diane / Chabova, Vera / Schirger, Alexander | 1999
38A-a
Renal artery stent placement in patients seventy-five years of age or older
Bloch, M.J. / Trost, D.A. / Pickering, T.G. / Sos, T.A. / August, P. | 1999
38A-b
Reliability of echo-doppler velocimetric indices in reflecting renal hemodynamics in normal and stenotic kidneys
Alberti, C. / Nador, B. / Palatresi, S. / Airoldi, F. / Marana, I. / Bencini, C. / Lovaria, A. / Benti, R. / Longari, V. / Morganti, A. | 1999
38A-c
Urinary tetrahydro-aldosterone (thald) is yet the most reliable test for diagnosing primary aldosteronism (PA).
Abdelhamid, S. / Krumme, B. / Röckel, A. | 1999
39A
27 cases of primary aldosteronism: A clinical profile
Parasuraman, R. / Khan, A. / Makos, G. / Talpos, G. / Steigerwalt, S. | 1999
39A-a
Relationship of 24 HR BP levels with sleep disordered breathing (SDB) in a community sample
Wright, J.T. / Redline, S. / Russo, L. / Taylor, A.L. / Aylor, J. / Clark, C. / Graham, G. / Liao, G. / Tishler, P.V. | 1999
39A-b
The siesta in the elderly: A new risk factor for mortality?
Bursztyn, M. / Ginsberg, G. / Hammerman-Rozenberg, R. / Stessman, J. | 1999
40A
Post transplant hypertension: Role of nitric oxide-oxidative stress relationship
Calò, L. / Milani, M. / Davis, P.A. / Rigotti, P. / Marchini, F. / Cantaro, S. / Livi, U. / D'Angelo, A. / Antonello, A. | 1999
40A-a
L-arginine for testing endothelium-derived factors in essential hypertension
Cottone, S. / Vadalà, A. / Vella, M.C. / Riccobene, R. / Neri, A.L. / Zagarrigo, C. / Amato, F. / Cerasola, G. | 1999
40A-b
Nifedipine GITS, but not hydrochlorothiazide, improves flow-dependent vasodilation of brachial artery in essential hypertensive patients
Muiesan, L. / Salvetti, M. / Monteduro, C. / Rizzoni, D. / Zulli, R. / Brun, C. / Corbellini, C. / Agbati-Rosei, E. | 1999
40A-c
Influence of salt intake on endothelium-derived products in essential hypertension
Bragulat, E. / de la Sierra, A. / Antonio, M.T. / Gómez-Angelats, E. / Giner, V. / Sierra, C. / Aguilera, M.T. / Jiménez, W. / Coca, A. | 1999
41A
Influence of cardiovascular risk on the efficacy of antihypertensive treatment in the insight trial
Rosenthal, T. / Brown, M.J. / Castaigne, A. / de Leeuw, P.W. / Mancia, G. / Ruilope, L.M. | 1999
41A-a
Calcium-channel blockade improves cardiovascular prognosis in older diabetic patients with isolated systolic hypertension
Staessen, J. / Thijs, L. / Celis, H. / Fagard, R. / Syst-Eur Investigators, | 1999
41A-b
Subgroup analysis of the placebo-controlled chinese trial on isolated systolic hypertension in the elderly
Wang, J.G. / Staessen, J.A. / Liu, L.S. / Systolic Hypertension in China (Syst-China) Trial Investigators, | 1999
41A-c
Comparison of the effects of candesartan and losartan on ambulatory blood pressure in patients with essential ambulatory hypertension. A forced titration study.
Lacourcière, Y. / Asmar, R. / CHAMP study group, | 1999
42A
Influence of age and gender on preventing myocardial infarction by antihypertensive treatment and aspirin in the hot study.
Kjeldsen, S.E. / Kolloch, R. / Zanchetti, A. / Hansson, L. | 1999
42A-a
Placebo-associated blood pressure response and adverse effects.
Materson, B.J. / Preston, R.A. / Reda, D.J. / Williams, D. | 1999
42A-b
Effect of amlodipine on progression of carotid atherosclerosis in patients with documented heart disease
Byington, R. / Riley, W. / Booth, D. / Herrington, D. / Hunninghake, D. / Mallon, S. / Miller, M. / Ramanathan, K.B. / Werns, S. / Furberg, C.D. et al. | 1999
42A-c
BP control, LV mass and plasma norepinephrine: enalapril vs felodipine ER vs nifedipine gits
Leenen, F.H.H. / Toal, C.B. / Myers, M.G. | 1999
43A
A001: In vivo gene-transfer of calcitonin gene-related peptide (CGRP) reduces hypoxia-induced pulmonary hypertension in the mouse.
Champion, H.C. / Bivalacqua, T.J. / D'Souza, F.M. / Toyoda, Kazunori / Heistad, D.D. / Hyman, A.L. / Kadowitz, P.J. | 1999
43A-a
A002: Identification of molecular determinants of atrial natriuretic peptide receptor - a by deletion mutagenesis
Pandey, K.N. / Kumar, R. / Pandey, K. / Cartledge, W. / Li, M. | 1999
43A-b
A003: Polymorphisms of the {gamma} subunit of the epithelial sodium channel in essential hypertension. Relationship with salt-sensitivity
Poch, E. / Giner, V. / González, D. / de la Sierra, A. / Botey, A. / Coca, A. / Darnell, A. / Rivera, F. | 1999
43A-c
A004: ACE-I gene polymorphism and arterial hypertension: Lack of association in afro-venezuelan populations
Delgado, A.J. / Palacio, R. / Farías, R. / Mago, V. / Cermeño, J. / Fragachán, F. | 1999
44A
A005: Polymorphisms of the renin-angiotensin genes and the outcome of BP and microalbuminuria in essential hypertension: A prospective three years follow-up study
Redon, Josep / Chaves, Javier / Pascual, Jose M / Armengod, Maria E | 1999
44A-a
A006: Influence of polymorphic sites at the apolipoprotein (apo) A-I/C-III genelocus on lipid metabolism and atherosclerosis
v. Petzinger, A. / Dudek, M. / Lennarz, M. / Willinek, W.A. / Ludwig, M. / Stumpe, K.O. | 1999
44A-b
A007: Lack of association between ace gene polymorphism and left ventricular hypertrophy in essential hypertension
Gómez-Angelats, E. / Enjuto, M. / Oriola, J. / Paré, J.C. / Francino, A. / Poch, E. / Coca, A. / de la Sierra, A. | 1999
44A-c
A008: Polymorphisms in candidate genes for blood pressure regulation in young men with elevated screening blood pressure
Fossum, E. / Høieggen, A. / Berge, K.E. / Moan, A. / Rostrup, M. / Berg, K. / Kjeldsen, S.E. | 1999
45A
A009: D/I polymorphism of the ace gene and left ventricular hypertrophy
Kuznetsova, T. / Staessen, J.A. / Wang, J. / Vlietinck, R. / Fagard, R. | 1999
45A-a
A011: Occurrence of post-percutaneous transluminal coronary angioplasty restenosis: Role of cholesteryl ester transfer protein and paraoxonase
Zee, R.Y.L. / Irurita, M. / Macaya, C. / Pintor, E. / Fernandez-Cruz, A. / Lindpaintner, K. | 1999
45A-b
A010: SCAI polymorphism of the atrial natriuretic peptide gene in patients with coronary heart disease below 50 years of age with and without arterial hypertension
Sobiczewski, W. / Gruchala, M. / Targołski, R. / Dubaniewicz, W. / Romanowski, P. / Rynkiewicz, A. | 1999
45A-c
A012: Relationship between variants of AT1R gene with blood pressure levels in a spanish population. Results of an epidemiologic study
Carrión, L. / Martinez, E. / Sanchis, C. / Artigao, L.M. / Divison, J.A. / Massó, J. / Garcia, F. / Rodriguez, B. / Vidal, A. / Escribano, J. et al. | 1999
46A
A013: Associated evaluation of differents variants of Angiotensinogen gen and the relation with blood pressure levels. Results of an epidemiologic study
Puras, Angel / Martinez, Esperanza / Sanchis, Carlos / Carrión, Lucinio / Artigao, Miguel / Divison, Juan A. / Escribano, Julio / Fernandez, Juan A. | 1999
46A-a
A014: Association of angiotensin-converting enzyme polymorphism with lifestyle and family history of hypertension in stage I hypertensives
Winnicki, M. / Accurso, V. / Hoffmann, M. / Pawlowski, R. / De Venuto, G. / Dorigatti, F. / Berton, G. / Krupa-Wojciechowska, B. / Palatini, P. / HARVEST Study Group, | 1999
46A-b
A015: A Linkage Between Angiotensinogen Gene Polymorphism and Stage I Hypertension - the Harvest Study
Winnicki, M. / Accurso, V. / Hoffmann, M. / Pawlowski, R. / Mos, L. / Piccolo, D. / Krupa-Wojciechowska, B. / Palatini, P. / HARVEST Study Group, | 1999
47A
B001: Blood pressure and fluid electrolyte balance in D1A dopamine receptor-deficient mice.
Meunier, A.V. / O'Connell, D.P. | 1999
48A
C001: Isolation and characterization of human basic calponin gene promoter.
Nakamura, M. / Kitami, Y. / Maguchi, M. / Fukuoka, T. / Takata, Y. / Igase, M. / Okura, T. / Hiwada, K. | 1999
49A
D001: Long term effect of bilateral ovariectomy on endothelial function in spontaneously hypertensive rats. Role of nitric oxide.
Riveiro, A. / Mosquera, A. / Maeso, R. / Gude, F. / Calvo, C. | 1999
49A-a
D002: Irbesartan and enalapril ameliorate endothelial dysfunction in ovariectomized spontaneously hypertensive rats.
Riveiro, A. / Mosquera, A. / Maeso, R. / Gude, F. / Calvo, C. | 1999
49A-b
D003: Large-conductance calcium-activated K+ channels are involved in EDHF-mediated relaxations in the rat renal artery
Jiang, F. / Li, C.G. / Rand, M.J. / Pharmacology Research Group, | 1999
49A-c
D004: Increased vascular endothelial growth factor (VEGF) immunostaining in preeclampsia
Simmons, Lisa A. / Hennessy, Annemarie | 1999
50A
D005: Renovascular hypertension, aortic superoxide production and endothelial function: Effect of perindopril and indapamide
Harrison, D.G. / Schiavi, P. / Falgui, B.T. | 1999
50A-a
D006: Compensatory rise in vascular NO synthase (NOS) in young and severe NOS fall in old SHR: Prevention with losartan therapy
Wang, X.Q. / Shahinfar, S. / Kivlighn, S. / Vaziri, N.D. | 1999
50A-b
D007: Comparative study on zofenopril, lisinopril, enalapril and captopril effects on endothelin-1 and nitric oxide production
Desideri, G. / Bellini, C. / Bravi, M.C. / Giuliani, E. / Santucci, A. / Ferri, C. | 1999
50A-c
D008: Chronic estrogen replacement reduces vasoconstriction to angiotensin II and serotonin in female hypertensive transgenic (mREN2)27 rat aorta
Li, P. / Figueroa, J.P. / Ferrario, C.M. / Ganten, D. / Brosnihan, K.B. | 1999
51A
D009: Amelioration of hypertension (HTN) and nitric oxide synthase (NOS) expression with antioxidant therapy in spontaneously hypertensive rats (SHR).
Vaziri, N.D. / Ni, Z. | 1999
51A-a
D010: Effect of increased reactive oxygen species (ROS) on nitric oxide (NO) synthase (NOS) expression in cultured human endothelial cells.
Vaziri, N.D. / Wang, X.Q. | 1999
51A-b
D011: Divergent effects of felodipine on nitric oxide synthase (NOS) expression in different forms of hypertension in rats.
Ni, Z. / Ding, Y. / Vaziri, N.D. | 1999
51A-c
D012: Endothelin-1 (ET-1) in renin-dependent hypertension and related cardiovascular disease
Rossi, G.P. / Sacchetto, A. / Rizzoni, D. / Bova, S. / Porteri, E. / Cargnelli, G. / Mazzocchi, G. / Nussdorfer, G.G. / Pessina, A.C. | 1999
52A
D013: Interactions between endothelin-1 and the renin-angiotensin-aldosterone system (RAAS)
Rossi, G.P. / Sacchetto, A. / Cesari, M. / Nussdorfer, G.G. / Pessina, A.C. | 1999
52A-a
D014: Up-regulation of renal endothelial and inducible nitric oxide synthase in obstructive nephropathy.
Wang, Z-Q. / Siragy, H.M. / Chevalier, R.L. / Carey, R.M. | 1999
52A-b
D015: In vivo experiments of {gamma}HuEPO-derived hypertension.
Nakamura, S. / Nakayama, K. / Yang, C.L. / Aoki, T. | 1999
52A-c
D016: Effect of angiotensin II and noradrenaline on nitric oxide in the rabbit kidney.
Nakamura, S. / Nakayama, K. / Yang, C.L. / Aoki, T. / Kakumu, S. | 1999
53A
D017: A dual mechanism is involved in the protective effects of CoCl2 in DOCA/salt hypertension
Lofberg, E. / Akinsanmi, A. / McGiff, J.C / Oyekan, A.O. | 1999
53A-a
D018: Heme oxygenase / carbon monoxide system regulates blood pressure cooperatively with nitric oxide in hypertension.
Ushiyama, M. / Morita, T. / Katayama, S. | 1999
53A-b
D019: Restoration of nitric oxide function in the glomerular microcirculation of SHR by prolonged candesartan administration: role of O2-.
Welch, W.J. / Wilcox, C.S. | 1999
53A-c
D020: Altered cell signaling, reduced PKC, increased ecNOS mRNA and vascular hyporeactivity of Bartter's (BS) and Gitelman's (GS) syndrome.
Calò, L. / Milani, M. / Ceolotto, G. / Cantaro, S. / Sartori, M. / Favaro, S. / D'Angelo, A. / Semplicini, A. | 1999
54A
D021: VIPGC-NO preserves intrinsic function of VIP but acquires NO-like activities.
Jia, L. | 1999
54A-a
D022: Cytosolic proteins from human neutrophils bind to endothelial nitric oxide synthase mRNA: Regulation by tumor necrosis factor alpha.
Sánchez de Miguel, L. / De Frutos, T. / Farré, J. / Arriero, M.M. / Romero, J. / Rico, L.A. / Gómez, J. / González-Fernández, F. / Rodríguez-Feo, J.A. / Guerra, J.I. et al. | 1999
54A-b
D023: Endothelial dysfunction in a group of essential hypertensive patients related to salt-sensitivity
Bragulat, E. / de la Sierra, A. / Antonio, M.T. / Gómez-Angelats, E. / Giner, V. / Sierra, C. / Aguilera, M.T. / Jiménez, W. / Coca, A. | 1999
54A-c
D024: Relationship between endothelin and insulin-like growth factor-1 in essential hypertension.
Andronico, G. / Ferraro-Mortellaro, R. / Mangano, M.T. / Ferrara, L. / Lamanna, D. / Cerasola, G. | 1999
55A
D025: Preserved vascular responsiveness to acetylcholine in uncomplicated essential hypertensive patients
Dell'Omo, G. / Bandinelli, S. / Penno, G. / Pedrinelli, R. / Mariani, M. | 1999
55A-a
D026: Adolescence as a risk factor of pregnancy-induced hypertension (PIH). Relationship to endothelial function.
Barroso, S.G. / Duarte, A.V.B. / Morandi, V. / Silveira, C.S. / Alves, M.P.S. / Francischetti, E.A. / Fagundes, V.G.A. | 1999
55A-b
D027: Endothelial dysfunction marker allow the early diagnosis of pregnancy-induced-hypertension (PIH) in adolescents.
Duarte, A.V.B. / Barroso, S.G. / Morandi, V. / Alves, M.P.S. / Melo, V.C.L. / Francischetti, E.A. / Fagundes, V.G.A. | 1999
55A-c
D028: Vitamin E counteracts early VCAM-1 activation in hypercholesterolemic subjects.
Ferri, C. / Desideri, G. / Giuliani, E. / Bellini, C. / Santucci, A. | 1999
56A
D029: Simvastatin counteracts early endothelial activation in hypercholesterolemic hypertensives and normotensives. A fundamental tool for cardiovascular prevention?
Ferri, C. / Desideri, G. / Baldoncini, R. / Bellini, C. / Santucci, A. | 1999
56A-a
D030: L-arginine at a dose above 100 mg/kg is not suitable to examine endothelial function of renal vasculature.
Delles, C. / Jacobi, J. / Schlaich, M.P. / John, S. / Schmieder, R.E. | 1999
56A-b
D031: Synergistic bradycardia related to simultaneous infusion of L-arginine and acetylcholine.
Houghton, J.L. / Chander, R.C. / Kuhner, P.A. / Fein, S.A. / Carr, A.A. | 1999
56A-c
D032: Effect of uncomplicated hypertension on coronary vasoreactivity among similar African and white American subjects.
Houghton, J.L. / Fein, S.A. / Smith, V.E. | 1999
57A
D033: Effect of antihypertensive treatment on flow-dependent vasodilation of brachial artery in essential hypertensive patients
Muiesan, L. / Salvetti, M. / Monteduro, C. / Rizzoni, D. / Zulli, R. / Brun, C. / Corbellini, C. / Agabiti, Rosei E | 1999
57A-a
D034: Nifedipine improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension
Virdis, A. / Taddei, S. / Buralli, S. / Ghiadoni, L. / Magagna, A. / Salvetti, A. | 1999
57A-b
D035: Effect of candesartan on endothelial function in the peripheral circulation of essential hypertensive patients.
Ghiadoni, L. / Virdis, A. / Taddei, S. / Magagna, A. / Vivaldi, S. / Notari, M. / Salvetti, A. | 1999
57A-c
D036: Vitamin C improves age-related endothelial dysfunction
Virdis, A. / Ghiadoni, L. / Salvetti, G. / Taddei, S. / Sudano, I. / Salvetti, A. | 1999
58A
E001: Is the central vasopressinergic system stimulated by angiotensin II?
Muders, F. / Elsner, D. / Bahner, U. / Jandeleit, K. / Riegger, G.A.J. / Palkovits, M. | 1999
58A-a
E002: Ouabain or an isomer is one of several inhibitors of Na-K-ATPase in human urine.
Kramer, H.J. / Bäcker, A. / Krampitz, G. / Pohlentz, G. | 1999
58A-b
E003: Effect of age on renal responses to COX-2 inhibitors, rofecoxib (VIOXX™, MK-0966), celecoxib and meloxicam, in conscious dogs.
Siegl, P.K.S. / Chan, C.C. / Bohn, D.L. / Evans, R.M. / Bunting, P.B. / Soper, K.A. / Patrick, D.H. | 1999
58A-c
E004: Receptor-mediated vasodilation effect of angiotensin 1-7(Ang 1-7) in the isolated rabbit afferent arteriole (Af-Art)
Ren, Y. / Garvin, J.L. / Carretero, O.A. | 1999
59A
E005: Correlates of vasodilatory effects of insulin in nondiabetic subjects.
Sung, B.H. / Shah, K. / Kidambi, S. / Wilson, M.F. | 1999
59A-a
E006: An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth
Tsuruda, T. / Kato, J. / Kitamura, K. / Imamura, T. / Koiwaya, Y. / Eto, T. | 1999
59A-b
E007: Elevated plasma levels and urinary excretion of ouabain like compound in cardiovascular deseases
Tóth, M. / Beck, M. / Horkay, F. / Szokodi, I. / Turbucz, P. / Szalay, KSz. / Leppäluoto, J. / deChâtel, R. | 1999
59A-c
E008: Humoral aspects of blood pressure rise in the morning at essential hypertension.
Svyshchenko, E. / Yarinkina, O. / Mkhytarian, L. / Mishchenko, L. / Kasimirko, E. / Rovenskaya, I. | 1999
60A
E009: Orthostatism modifies insulin-like growth factor 1 and insulin plasma levels in essential hypertension.
Andronico, G. / Ferrara, L. / Mangano, M.T. / Ferraro-Mortellaro, R. / Lamanna, D. / Cerasola, G. | 1999
60A-a
E010: Use of monoclonal antibodies for affinity chromatography of parathyroid hypertensive factor
Krylova, S. / Lauber, C. / Zhang, M. / Shan, J. / Benishin, C.G. | 1999
60A-b
E011: Plasma catecholamines and clonidine test in the differential diagnosis of essential hypertension and pheochromocytoma.
Mediavilla, J.D. / López de la Torre, M. / Piédrola, G. / Hidalgo, C. / León, L. / Aliaga, L. / Pinel, P. / Fernández, C. | 1999
60A-c
E012: Divergent effects of dihydropyridine and phenylalkylamine calcium antagonist on plasma norepinephrine before and after cold pressor test in mild to moderate hypertension.
Lefrandt, J.D. / Urbigkeit, A. / Sevre, K. / Castellano, M. / Hausberg, M. / Fallon, M. / Fluckiger, L. / Heitmann, J. / Rostrup, M. / Agabiti Rosei, E. et al. | 1999
61A
E013: Nitric oxide, cyclic guanosin monophosphate, endothelin-1, erythropoietin: relationship with ambulatory blood pressure monitoring in essential hypertension
Parrini, M. / Angelini, D. / Carlini, A. / Bigongiari, P. / Nardini, G. / Fiorini, I. / Antonelli, A. | 1999
62A
F001: Estrogen receptor-{alpha} in tumorigenesis: inhibition of cell growth, cell migration, vascular endothelial growth factor and integrin {alpha}v{beta}3 in ECV304 cells
Ali, S.H. / O'Donnell, A.L. / Balu, D. / Pohl, M.B. / Seyler, M.J. / Mousa, S. / Mohamed, S. / Dandona, P. | 1999
62A-a
F002: Ang II type 2 receptor activates JNK/SAPK-dependent signaling pathways.
Diep, Q. / Touyz, R.M. / Wu, X-H. / He, G. / Webb, A. / Schiffrin, E.L. | 1999
63A
G001: Abnormalities of the calcium pump in essential hypertension
Sobrino, J. / de la Sierra, A. / Ribera, L. / Adrian, M.J. / Aguilera, M.T. / Coca, A. | 1999
63A-a
G002: Urinary aldosterone and sodium reabsorption in the distal nephron correlate with the activity of amiloride-sensitive sodium channels.
Wang, Q. / Burnier, M. / Maillard, M. / Parisod, Y. / Brunner, H.R. / Nussberger, J. | 1999
63A-b
G003: Altered cAMP-response in T594M variant of amiloride sensitive sodium channel in human transformed lymphocytes
Cui, Y. / Su, Y.R. / Layne, M. / Carter, V. / Menon, A.G. / Reif, M.C. / Pun, R.Y.K. | 1999
63A-c
G004: Distinction between bumetanide-sites at rat Na-K-Cl cotransporters BSC1 and BSC2
Pirot, D. / Alvarez-Guerra, M. / Nazaret, C. / Hannaert, P. / Garay, R.P. | 1999
64A
G005: Identification of the chloride transport protein responsible for the increased renal NaCl reabsorption in Dahl salt-sensitive rats
Alvarez-Guerra, M. / Garay, R.P. | 1999
64A-a
G008: Cellular calcium/magnesium antagonism in primary hypertension
Kisters, K. / Barenbrock, M. / Hausberg, M. / Westermann, G. / Kosch, M. / Rahn, K.H. | 1999
64A-b
G006: Effect of estrogen replacement therapy on blood pressure and intracellular electrolytes
Cardona, M.Q. / de la Sierra, A. / Aguilera, M.T. / Coca, A. / Urbano-Márquez, A. | 1999
64A-c
G007: The significance of a decreased erythrocyte potassium in the management of severe essential hypertension.
Delgado-Almeida, A. / Delgado-Leon, C. / Delgado, M.C. | 1999
65A
G009: Early signs of insulin resistance in normotensive offspring of hypertensives with low RBC K content
Delgado, M.C. / Delgado-Leon, C. / Delgado-Almeida, A. | 1999
65A-a
G010: Red blood cell Na+/K+ atpase and Na+/K+/2CL- countertransport activity in patients with syndrome X.
Gaspardone, A. / Ferri, C. / Crea, F. / Tomai, F. / Versaci, F. / Desideri, G. / Bellini, C. / Santucci, A. / Gioffrè, P.A. | 1999
65A-b
G011: Insulin and membrane function of erythrocytes in essential hypertension -an electron paramagnetic resonance investigation-
Kinoshita, Y. / Tsuda, K. / Nishio, I. / Masuyama, Y. | 1999
66A
H001: Ambulatory blood pressure and procolagen amino-terminal polypeptide (P-III-P)
Moreira, C.S. / Serejo, F. / Ramalhinho, V. / Gato-Varela, M. / Alcântara, P. / Braz-Nogueira, J. | 1999
66A-a
H002: Presence of chlamydia pneumoniae in cultured human smooth muscle cells from arteries with and without atherosclerotic lesions
Korakianitou, I.K. / Sudmann, M. / Lennarz, M. / Lewen, V. / Böhm, C. / Schnabel, D. / Stumpe, K.O. | 1999
66A-b
H003: Highly increased ICAM-1 levels in essential hypertension: correlation to proinflammatory cytokines levels.
Paletas, K. / Boura, P. / Magoula, I. / Alexiadis, S. / Tsapas, A. | 1999
66A-c
H004: Essential hypertension, unstable angina and the immune link in homeostasis.
Tashchuk, V.K. / Melnitsky, I.V. / Dubrovska, G.V. / Polyanska, O.S. / Ilashchuk, I.I. | 1999
67A
I001: High glucose and hyperinsulinemia inhibit MKP-1 expression in aortic smooth muscle cells by blocking the induction of iNOS
Begum, N. / Ragolia, L. / Duddy, N. / Koshy, B. | 1999
67A-a
I002: Hemodynamic effects of an intravenous glucose tolerance test in normotensives subjects
Rhéaume, C. / Waib, P. / Marceau, M. / Lacourcière, Y. / Cléroux, J. | 1999
67A-b
I003: Comparison of regional hemodynamic responses after exhausting exercise in normotensive and hypertensive subjects.
Marceau, M. / Rhéaume, C. / Lacourcière, Y. / Cléroux, J. | 1999
67A-c
I004: {alpha}-soomth muscle actin (SMA) and collagen type III (COLIII) in myocardium (MC) of diabetic rats untreated with insulin.
Toblli, J.E. / Stella, I. / Nyberg, C. / Ferder, L. / Inserra, F. | 1999
68A
I005: Defective dopamine receptor G-protein function contributes to reduced dopamine-mediated inhibition of Na,K-ATPase in proximal tubules of obese zucker rats
Hussain, Tahir / Beheray, Sucheta A. / Lokhandwala, Mustafa F. | 1999
68A-a
I007: Hyperinsulinaemia and reninaldosterone system in morbid obesity.
Andronico, G. / Ferraro-Mortellaro, R. / Ferrara, L. / Mangano, M.T. / Mulé, G. / Piazza, G. / Cerasola, G. | 1999
68A-b
I006: Dissociation between diabetic retino and nephropathy in experimental type II diabetes. Effects of irbesartan.
Garcia-Robles, R. / Villalba, F. / Gonzalez, O. / Villa, E. / Rabano, A. / Rocamora, A. / Moreno, B. / Calvo, S. / Sancho, J.M. / Ruilope, L.M. | 1999
68A-c
I008: Hypertension and visceral fat accumulation: a community-based study in Oporto, Portugal.
von Hafe, P. / Pérez, A.M. / Froufe, P. / Ramos, E. / Lopes, C. / Maciel, M.J. / Barros, H. | 1999
69A
I009: Dual effects of epinephrine on blood glucose during hyperinsulinemia in borderline hypertensive young men
Høieggen, A. / Fossum, E. / Moan, A. / Eide, I. / Kjeldsen, S.E. | 1999
69A-a
I010: Insulin resistance and ACE-I gene polymorphism in Afro-venezuelan hypertensive patients.
Delgado León, Antonio J. / Farías, Rosa / Fragachán, Francisco | 1999
69A-b
I011: Insulin resistance in hypertensive Afro-venezuelan subjects.
Farías, R. / Delgado, A.J. / Palacio, R. / Mago, V. / Cermeño, J. / Bredy, R. / Fragachán, F. | 1999
69A-c
I012: Interrelation between blood pressure and glucose and lipid parameters in men with arterial hypertension and diabetes type-2 in the post-myocardial infarction period.
Matveeva, S.A. | 1999
70A
I013: Hypotensive effect of lacidipine vs lisinopril in hypertensive NIDDM patients.
Kurashvili, R.B. / Chumburidze, V.B. / Kikalishvili, T.T. / Asatiani, N.G. | 1999
70A-a
I014: Captopril effectivity in patients with hypertension and diabetes
Khelashvili, M.G. / Kurashvili, R.B. / Chumburidze, V.B. | 1999
70A-b
I015: Stress-induced pulse pressure in young adult mild hypertensives with insulin resistance
Nazzaro, P. / Manzari, M. / Merlo, M. / Triggiani, R. / Scarano, A.M. / Ciancio, L. / Vapore, G. / Pirrelli, A. | 1999
70A-c
I016: Effects of Celipropol, Irbesartan and Lisinopril on insulin sensitivity in non diabetic hypertensive patients.
Mugellini, A. / Poletti, L. / Zoppi, A. / Lazzari, P. / Preti, P. / Corradi, L. / Fogari, R. | 1999
71A
I017: Blood pressure increase in hyperglycemia
Cinar, Y. / Şenyol, A.M. / Başar, M. | 1999
71A-a
I018: Dietetic profile and the insulin resistance syndrome in overweight hypertensive Brazilian patients
Barroso, S.G. / Fagundes, VGA. / Rodrigues, MLG. / Sanjuliani, A.F. / Silveira, C.S. / Tronco, ALS. / Neto, J.F. / Francischetti, E.A. | 1999
71A-b
I019: Vitamin C improves acetylcholine-stimulated vasodilation in obese subjects
Perticone, F. / Ceravolo, R. / Cloro, C. / Candigliota, M. / Ventura, G. / Mattioli, P.L. | 1999
71A-c
I020: Syndrome W: a new model of hyperinsulinemia, hypertension and other CAD risk factors in healthy midlife women with normal glucose tolerance
Mogul, H.R. / Weinstein, B. / Mogul, D. | 1999
72A
I021: Physiologic doses of insulin decrease central systolic blood pressure without changing peripheral vascular resistance in normal subjects
Vehkavaara, S. / Westerbacka, J. / Yki-Järvinen, H. | 1999
72A-a
I022: Dynamics of the angiotensin-converting enzyme activity and insulin resistance in patients with metabolic syndrome treated with moxonidin.
Britov, A.N. / Aparina, T.V. / Gomazkov, O.A. / Nebieridze, D.V. / Metelskaya, V.A. / Mamedov, M.N. | 1999
72A-b
I023: Relationships between chronic hyperinsulinemia, heart rate variability.
Galinier, M. / Fourcade, J. / Boveda, S. / Solera, S. / Solera, M.L. / Massabuau, P. / Cabrol, P. / Fauvel, J.M. / Valdiguie, P. / Bounhoure, J.P. | 1999
72A-c
I024: Effects of weight loss on multiple cardiovascular disease risk factor reduction: One-year of treatment with Orlistat.
Lucas, C. / Hauptman, J. / Dallas, J. / Nichols, G. / Segal, K.R. | 1999
73A
I025: Insulin resistance and hypertension in lean postmenopausal women.
Feldstein, C.A. / Renauld, A. / Cauterucci, S. / Akopian, M. / Calcagno, M. / Garrido, D. | 1999
73A-a
I027: Hypertension and obesity. Influence of life style modifications
Santos, R.M. / Macedo, M.E. / Monteiro, A. / Freitas, J. / Marujo, C. / de Freitas, A.Falcão | 1999
73A-b
I026: Handgrip test as a tool to assess modifications in autonomic control of heart rate at essential hypertension
Voita, D. / Mackevics, V. / Vitols, A. | 1999
73A-c
I028: Obesity, high blood pressure and autonomic nervous system.
Santos, R.M. / Freitas, J. / Carvalho, M.J. / Macedo, M.E. / de Freitas, A Falcão | 1999
74A
I029: Duration of diabetes affects cardiac function in asymptomatic, normotensive type II diabetes.
Shah, K. / Vallabhan, T. / Kidambi, S. / Sung, B.H. | 1999
74A-a
I030: Prevalence of impaired diurnal variation in asymptomatic, normotensive type II diabetics.
Kidambi, S. / Sung, B.H. / Shah, K. / Vallabhan, T. / Wilson, M.F. | 1999
74A-b
I031: Effects of supplemented Taohe Chengqi Decoction in treating insulin resistance in rats with non-insulin dependent diabetes mellitus
Ze-en, Li. / An-zhong, Lin / Zhang-zhi, Zhu / Wen-jiu, Chai | 1999
74A-c
I032: Profile of insulin secretion over 24 hours period in hypertensive and normotensive obese men and blood pressure.
González-Albarrán, O. / Calvo, S. / Villalba-Díaz, F. / Hurtado, A. / Sancho, J. / García-Robles, R. | 1999
75A
I033: Results of an outcome survey in 2414 unselected patients with diabetes type 2: Effects of cilazapril on renal and cardiovascular function
Delles, C. / Veelken, R. / Schmieder, R.E. | 1999
75A-a
I034: Prevalence of hypertension and occurrence of new cases of hypertension in diabetic subjects: Correlation with their antidiabetic treatment
Bourmendil, E.F. / Mugnier, C. | 1999
75A-b
I035: The association between left ventricular hypertrophy, hyperleptinemia and the insulin resistance syndrome.
Pladevall, M. / Guyer, H.M. / Yañez, A.M. / Sadurní, J. / Falces, C. / Planas, A. | 1999
76A
J001: BP dependent and independent effects of salt on the pathogenesis of hypertension induced renal damage (HIRD) in the stroke prone SHR (SHRsp).
Griffin, K. / Picken, M. / Churchill, P. / Churchill, M. / Webb, C. / Bidani, A. | 1999
76A-a
J002: Aldosterone reverses the protective effects of adrenalectomy against end-organ damage in stroke-prone spontaneously hypertensive rats
Rocha, R. / Chander, P.N. / Zuckerman, A. / Mullen, D. / Bhasin, K. / Stier, C.T. | 1999
76A-b
J003: Oxidative stress in hypertensive with left ventricular hypertrophy= preliminary report.
Broche, F.J. / Cespedes, E. / Garcia, J. / Leal, E. / Sanchez, R. | 1999
76A-c
J004: Altered resistance artery wall composition in SHR: Normalization by irbesartan.
Intengan, H.D. / Li, J.S. / Schiffrin, E.L. | 1999
77A
J005: Silent myocardial ischemia and the relationship with cardiovascular endorgan damage in newly found hypertensives.
Terpstra, W.F. / May, J.F. / Smith, A.J. / de Graeff, P.A. / Crijns, H.J.G.M. | 1999
77A-a
J006: Abnormal baseline endothelial dysfunction and thrombogenesis are related to prognosis in hypertension
Edmunds, E. / Blann, A.D. / Beevers, D.G. / Lip, GYH. | 1999
77A-b
J007: Relation between casual blood pressure and target organ damage in untreated hypertensive course
Takatsugi, K. / Okuda, Y. / Konishi, S. / Mukai, M. / Matsuzaki, K. / Murakami, E. | 1999
77A-c
J008: Protective effect of Benazepril on kidney in patients with essential hypertension.
Shude, Tang / Hang, Qi Wen | 1999
78A
J009: Comparison of pulse wave velocity among normotensives, white coat and sustained hypertensives with and without diabetes or dislipidemia.
Ribeiro, L. / Santos, A. / Gama, G. / Asmar, R. / Polónia, J. | 1999
78A-a
J010: Humoral and hemodynamic correlates of hepatocyte growth factor in end stage renal disease
Malatino, L.S. / Tripepi, G. / Benedetto, F.A. / Mallamaci, F. / Marino, C. / Garozzo, M. / Di Vincenzo, F. / Arena, C. / Cataliotti, A. / Bellanuova, I. et al. | 1999
78A-b
J011: Exercise blood pressure as a determinant of left ventricular mass and geometry in patients with hypertension.
Franceschini, L. / Gallo, A. / Zamboni, A. / Albani, A. / Tomei, R. / Rossi, L. / Zanolla, L. / Zardini, P. | 1999
78A-c
J012: Transvascular albumin leakage and urinary albumin excretion in uncomplicated essential hypertensive subjects
Pedrinelli, R. / Dell'Omo, G. / Penno, G. / Bandinelli, S. / Giorgi, D. / Di Bello, V. / Mariani, M. | 1999
79A
J013: Microalbuminuria and concentric hypertrophy in essential hypertension
Pedrinelli, R. / Di Bello, V. / Dell'Omo, G. / Giorgi, D. / Bandinelli, S. / Penno, G. / Mariani, M. | 1999
79A-a
J014: Is there a correlation between left ventricular hypertrophy, hypertension and age?
Ciocon, J.O. / Capili-Rosenkranz, Erlinda | 1999
79A-b
J015: Non-dipper hypertensives have increased microalbuminuria irrespectively of diabetes mellitus
Vyssoulis, G.P. / Triantafillou, A.J. / Karpanou, E.A. / Toutouza, M.G. / Tselika, C.S. / Toutouzas, P.K. | 1999
79A-c
J016: Atorvastatin and Vitamin C on endothelial function of hypercholesterolemic patients
Perticone, F. / Ceravolo, R. / Maio, R. / Iacopino, S. / Ventura, G. / Giancotti, F. / Mattioli, P.L. | 1999
80A
J017: Hypertensive left ventricular hypertrophy but not ace-gene polymorphism affects adverse outcomes.
Perticone, F. / Schillaci, G. / Verdecchia, P. / Cuccurullo, O. / Cosco, C. / Maio, R. / Trapasso, M. / Mattioli, P.L. | 1999
80A-a
J018: Carotid thickening in hypertensives and white coat hypertensives.
Alcântara, P. / Moreira, C. / Oliveira, V. / Braz-Nogueira, J. / Ravara, L. | 1999
80A-b
J019: Endothelial dysfunction is an independent predictor of left ventricular hypertrophy in untreated hypertension
Marchesi, S. / Schillaci, G. / Vaudo, G. / Lupattelli, G. / Verdecchia, P. / Mannarino, E. | 1999
80A-c
J020: Relationship between heart rate during ambulatory blood pressure monitoring and urinary albumin excretion in mild hypertension.
Armario, P. / Hernández del Rey, R / Torres, G. / Martin-Baranera, M. / Almendros, M.C. / Ruigómez, J. / Pardell, H. | 1999
81A
J021: High prevalence of retinal vascular changes in early phases of essential hypertension
Lonati, L. / Cuspidi, C. / Sampieri, L. / Zaro, T. / Michev, I. / Macca, G. / Valagussa, L. / Leonetti, G. / Zanchetti, A. | 1999
81A-a
J022: Defining the relationship between BP and target organ damage: The hot target-organ substudy
Haley, W.E. / Harris, T.M. / Tucker, C.T. / Zachariah, P.K. | 1999
81A-b
J023: Early changes in left ventricular function and geometry in patients with mild mitral or aortic regurgitation. the life study
Papademetriou, V. / Narayan, P. / Dahlof, B. / Wachtell, K. / Gerdts, E. / Nieminne, M. / Nielsen, J. / Devereux, R.B. | 1999
81A-c
J024: Microalbuminuria is an integrated marker of increased cardiovascular risk and target organ damage in essential hypertension
Pontremoli, R. / Ravera, M. / Viazzi, F. / Berruti, V. / Leoncini, G. / Nicolella, C. / Bezante, G.P. / Del Sette, M. / Lotti, R. / Sacchi, G. et al. | 1999
82A
J025: Prediction of left ventricular mass (LVM) in the elderly by casual measurement and ambulatory blood pressure monitoring (ABPM)
Ruiz-Nodar, J.M. / Arco-Galán, C. / Aguilar, R. / Martinez-Elbal, L. / Méndez-García, J. / Pizzaro, A. / Fernández, M. / Gabriel, R. / Suárez, C. | 1999
82A-a
J026: Microalbuminuria, pulse pressure, left ventricular hypertrophy and myocardial ultrasonic textural parameters (videodensitometry) in arterial hypertension
Di Bello, V. / Pedrinelli, R. / Giorgi, D. / Bertini, A. / Talini, E. / Dell'Omo, G. / Caputo, M.T. / Cioppi, A. / Giusti, C. | 1999
82A-b
J027: Do patients with de novo hypertension differ from those with previously known hypertension when malignant phase hypertension occurs?
Lip, G.Y.H. / Beevers, M. / Beevers, D.G. | 1999
82A-c
J028: Malignant hypertension: the 10-year experience of a hypertension unit in athens, greece
Efstratopoulos, A.D. / Voyaki, S.M. / Lydakis, H. / Meikopoulos, M. / Kolettas, C.h. / Karabatsaki, H. / Eliadi, H. | 1999
83A
J029: Night-time blood pressure is more important than daytime blood pressure for left ventricular mass in hypertension
Missault, L.H. / De Buyzere, M.L. / Duprez, D.A. / Clement, D.L. | 1999
83A-a
J030: Microalbuminuria in never-treated hypertensives : relations with left ventricular characteristics, insulin sensitivity and genetic predisposition to hypertension.
Grandi, A.M. / Zanzi, P. / Santillo, R. / Gaudio, G. / Broggi, R. / Imperiale, D. / Colombo, S. / Guasti, L. / Bertolini, A. / Venco, A. | 1999
83A-b
J031: Regression of left ventricular hypertrophy and heart rate variability in hypertensive patients
Tasić, I.S. / Lović, B.K. / Ilić, S. / Dordević, D. / Deljanin-Ilić, M. / Nikolić, A. / Milovanović, I. / Petrović, D. / Lović, D. / MiladinovićTasić, N. | 1999
83A-c
J032: Relationship between left ventricular mass, blood pressure and microalbuminuria in a secondary referral hypertension clinic
Gatzka, C.D. / Reid, C.M. / Lux, A. / Dart, A.M. / Jennings, G.L. | 1999
84A
J033: Correlates of left ventricular mass in a population sample aged 35 to 64 years
Jula, A. / Karanko, H. / Aaltonen, T. | 1999
84A-a
J034: Screening of elderly patients for abdominal aortic aneurysms during echocardiography
Grandinetti, O. / Matrangolo, E. / Ortale, C. / Chiappetta, P. / Lidonnici, D. / De Marco, A. / Mirabelli, F. / Benatti, G. / Italian Cardiogeriatric Group (GIC-A.N.C.E.), | 1999
85A
K001: The barlovento study: prevalence of arterial hypertension in black communities of venezuela.
Farías, R. / Delgado, A.J. / Guggisberg, W. / Alvarez, R. / Chuki, E. / Fragachán, F. | 1999
85A-a
K002: Anthropometric evaluation and its correlation with blood pressure: A study in afro-venezuelan population
Delgado, AJ. / Farías, R. / Guggisberg, W. / Alvarez, R. / Chuki, E. / Fragachán, F. | 1999
85A-b
K003: Hypertensive patients evaluated in the arterial hypertension unit in 1997: Clinical-epidemiological features
Guggisberg, W. / Farías, R. / Delgado, A.J. / Alvarez, R. / Chuki, E. / Fragachán, F. | 1999
85A-c
K004: Dehydroepiandrosterone serum levels and arterial hypertension: Study in afro-venezuela men
Fragachán, F. / Delgado, A.J. / Palacio, R. / Farías, R. / Mago, V. / Cermeño, J. | 1999
86A
K005: Is the prevalence of hyperuricemia in essential hypertension decreasing?
Campo, C. / Segura, J. / Alcázar, J.M. / Ruilope, L.M. | 1999
86A-a
K006: Risk factor clustering in hypertension; significance of NCEP-II, EAS and 1997 diabetes expert committee reports for the implementation of JNC-VI guidelines
Stern, Naftali / Grosskop, Itamar / Shapira, Itzchak / Kisch, Eldad / Isaacov, A. / Limor, Rona / Baz, Merav / Leshem, Yehoshua / Flatau, Edith / Miller, Agnes et al. | 1999
86A-b
K007: The association of calcium channel blocker and cancer: Does the hypothesis withstand the scrutiny of the epidemiologic principles of causation?
Roht, L.H. / Rubenstein, E.B. / Mason, R.P. / Beach, C.L. / Sun, C.C. / Martin, C.G. / Manzullo, E. | 1999
86A-c
K008: Hypertension in children: Care in diagnosis
Machado, C.E. / Souza, R. / Peccini, K. / Boscoli, A. / Baptista, L. / Barbieri, E. / Misael, A.M. | 1999
87A
K009: Variability of office blood pressure during one-year and cardiovascular accidents in the elderly treated hypertensives
Hata, Y. / Kimura, Y. / Muratani, H. / Fukiyama, K. / Kawano, Y. / Ozawa, T. / Yokouchi, M. / Imai, Y. / Ashida, T. / Fujii, J. et al. | 1999
87A-a
K010: Pretreatment blood pressure, as a risk factor for 21-year mortality, decreases with increasing age.
Perry, H.M. / Miller, J.P. / Baty, J.D. / Carmody, S.E. / VA HSTP Group, | 1999
87A-b
K011: Prevalence of left ventricular hypertrophy in elderly population
Ruiz-Nodar, J.M. / Aguilar, R. / Martinez-Elbal, L. / Arco-Galán, C. / Méndez-García, J. / Fernández, M. / Pizarro, A. / Gabriel, R. / Suarez, C. | 1999
87A-c
K012: Personal digital assistant (hand-held) computers technology for cardiovascular risk factor management
Phillips, R.A. / Kannry, J. / Siu, A. / Hwang, C. | 1999
88A
K013: Improved outpatient hypertension control with disease management guidelines.
Townsend, R.R. / Shulkin, D.J. / Bernard, D. | 1999
88A-a
K014: Four year follow-up of treated patients with nocturnal hypertension controlled by ambulatory blood pressure monitoring
Carmona, J. / Amado, P. / Vasconcelos, N. / Almeida, L. / Santos, I. / Nazaré, J. | 1999
88A-b
K015: Long-term prognosis of hypertension in pregnancy
Marín, R. / Gorostidi, M. / Portal, C. / Sánchez, M. / Sánchez, E. / Fernández, F. / Álvarez, J. | 1999
88A-c
K016: Raised serum uric acid levels are associated with increased risk for stroke and heart attack
Ward, H. / Pan, D. | 1999
89A
K017: Hypertension in pregnancy: Changes during a 24-year observational study
Marín, R. / Gorostidi, M. / Portal, C. / Sánchez, M. / Fernández, F. / Álvarez, J. | 1999
89A-a
K018: Sex-specific associations of hypertension with lipid levels in a representative sample
Ferrières, J. / Raetz, S. / Amouyel, P. / Arveiler, D. / Ruidavets, J.B. / Cottel, D. / Lamamy, N. / Bingham, A. / Ducimetière, P. | 1999
89A-b
K019: Predictive role of gender on blood pressure control
Pannarale, G. / Acconcia, M.C. / Gaudio, C. / Ferri, F. / Pannitteri, G. / Schiariti, M. | 1999
89A-c
K020: Carotid intima-media thickness and coronary heart disease risk factors in a low-risk population
Ferrières, J. / Elias, A. / Ruidavets, J.B. / Cantet, C. / Bongard, V. / Boccalon, H. | 1999
90A
K021: Atlas project: a global pharmacoeconomical evaluation of antihypertensive treatment
Degli Esposti, E. / Sturani, A. / Macini, P.L. / Buda, S. / Cocchi, R. / Di Nardo, A.M. / Fabbri, A. / Lucatello, A. / Pasi, A. | 1999
90A-a
K022: Association of sympathetic activity (resting heart rate) with serum cholesterol but not with blood pressure in young normotensive subjects
Weisser, B. / Mengden, T. / Grohé, C. / Lottermoser, K. / Vetter, H. | 1999
90A-b
K023: Arterial hypertension in children: The procorlujan 97 program. Preliminary results
Fernandez Contreras, R. / Gomez Llambi, H. / Villa, D. / Puglia, D. | 1999
90A-c
K024: Relationship between birth weight and adolescent and adult blood pressure and baroreflex sensitivity: A 14 years follow up study
Rabbia, F. / Veglio, F. / Cat Genova, G. / Martini, G. / Riva, P. / Grosso, T. / Morra di Cella, S. / Milan, A. / Chiandussi, L. | 1999
91A
K025: A working day evaluation of the dyslipidemia in a Spanish population ("JADE" study): A sub-analysis of the hypertensive patients.
Martínez-González, J. / Gómez-Gerique, J.A. / Fernández-Arias, I. / Espejo-Martínez, J. | 1999
91A-a
K026: Obesity influences the urinary sodium excretion in children and adolescents
Lurbe, Empar / Cremades, Beatriz / Torró, Isabel / Rodriguez, Concepción / Tacons, Jose / Alvarez, Vicente / Redon, Josep | 1999
91A-b
K040: The role of 24-hour blood pressure monitoring in predicting the development of sustained hypertension after 6 months of follow-up. Hospitalet study.
Hernández-del Rey, R. / Armario, P. / Martin-Baranera, M. / Sanchez, P. / Almendros, M.C. / Coca, A. / Pardell, H. | 1999
91A-c
K028: Gender differentials in blood pressure and cardiovascular disease in the Barbados eye study.
Hennis, A. / Wu, S-Y. / Nemesure, B. / Li, X. / Leske, M.C. / Barbados Eye Study Group, | 1999
92A
K029: Population blood pressure control in patients with diabetes and congestive heart failure.
L'Italien, G.J. / Lapuerta, P. | 1999
92A-a
K030: Awareness, treatment, and control of systolic blood pressure in the United States.
Lapuerta, P. / L'Italien, G.J. | 1999
92A-b
K031: High blood pressure levels prevalence in children from Braganca Paulista -- SP -- Brasil
Machado, C.E. / Souza, R. / Peccini, K. / Boscoli, A. / Baptista, L. / Sanoda, R. / Misael, A. | 1999
92A-c
K032: Is high blood pressure a predisposing factor to renal lithiasis?
Machado, C.E. / Souza, R. / Misael, A.M. / Sanoda, R.Y. / Salvatti, L.G. / Campos, C.P. / Santi, D.N. / Marzochi, L.M. / Domienikan, M.S. / Benedetti, M.E. | 1999
93A
K033: Treatment and control of hypertension in adult diabetics in Northwest Indiana.
Elliott, W.J. / Toth, S.J. / Stemer, A. / Cadwalader, J. / Inland/United Steelworkers of America Healthcare Network, | 1999
93A-a
K034: Clinical sequelae after becoming lost-to-follow-up in a tertiary hypertension clinic.
Elliott, W.J. | 1999
93A-b
K035: Pulse pressure and cardiovascular mortality in normotensive borderline and hypertensive subjects. Results of a Brisighella Heart Study.
Dormi, A. / Borghi, C. / Galletti, C. / Rimondi, S. / Gaddi, A. | 1999
93A-c
K036: Time -course and risk profile of isolated systolic hypertension in the young
Vriz, O. / Bettio, M. / Frigo, G. / Dorigatti, F. / Palatini, P. / HARVEST Study Group, | 1999
94A
K037: Clustering of cardiovascular risk factors in young adults: The Odense Schoolchild Study
Lambrechtsen, J. / Rasmussen, F. / Jacobsen, I.A. / Hansen, H.S. | 1999
94A-a
K038: Birth weight and cardiovascular risk factors in Japanese young adults.
Minami, J. / Suzuki, T. / Ohrui, M. / Ishimitsu, T. / Hisauchi, T. / Matsuoka, H. | 1999
94A-b
K039: Prevalence, awareness, treatment and control of hypertension in Greece: The Didima study.
Stergiou, G.S. / Thomopoulou, G.C. / Skeva, I.I. / Mountokalakis, T.D. | 1999
94A-c
K040: Role of age on the effects of blood pressure, heart rate, and cholesterol on cardiovascular mortality
Benetos, A. / Thomas, F. / Guize, L. | 1999
95A
K041: Prevalence, awareness, treatment and control of hypertension in people over eighty in Spanish population.
Saez, T. / Suarez, C. / del Arco, C. / Mendez, J. / Pizarro, A. / Fernandez-Escribano, M. / Gabriel, R. / Vega, S. / EPICARDIAN Study group, | 1999
95A-a
K042: Tracking of cardiovascular risk factors from childhood to adulthood: The Odense Schoolchild Study
Lambrechtsen, J. / Rasmussen, F. / Jacobsen, I.A. / Hansen, H.S. | 1999
95A-b
K043: Changes in blood pressure and adiposity throughout adulthood and their relationship to physical activity in overweight and never-overweight groups: The Fels Longitudinal Study.
Siervogel, R.M. / Wisemandle, W.A. / Towne, B. / Maynard, L.M. / Guo, S.S. / Chumlea, W.C. | 1999
95A-c
K044: Decreased prevalence and improved control of hypertension in the Czech population
Cífková, R. / Škodová, Z. / Hejl, Z. / Adámková, V. / Novozámská, E. / Pit'ha, J. / Jozífová, M. / Šraierová, D. / Hauserová, G. / Dušková, A. et al. | 1999
96A
K045: Pharmacologic treatment of hypertension among the South Carolina Medicaid population.
Lackland, D. / Egan, B. / Durkin, M. / Gunter, N. / Williams, B. | 1999
96A-a
K046: Non-insulin-dependent diabetes mellitus as an aggravating factor in hypertensive patients with carotid atherosclerosis
Grandinetti, O. / Mazzei, B. / Pranno, L. / Zottola, C. / Muti, V. | 1999
96A-b
K047: Yield of renal arteriography (RA) in the evaluation of pediatric hypertension.
Shahdadpuri, J. / Frank, R. / Gauthier, B.G. / Siegel, D.N. / Trachtman, H. | 1999
97A
A001: Effect of protease inhibitors on angiotensin-converting enzyme activity in human T-lymphocytes.
Lijnen, P. / Fagard, R. / Petrov, V. | 1999
97A-a
A002: Effects of different doses of moexipril and HCTZ alone or in combination on postmenopausal osteoporosis and hypertension in ovariectomized spontaneously hypertensive rats
Stimpel, M. / Yao, W. / Lu, J. / Setterberg, R.B. / Zhou, H. / Jee, WSS. / Ma, Y.F. | 1999
97A-b
A003: Renal tubular Ang I, Ang II, renin, and prorenin prosequence immunostaining in Dahl S and R rats: Lack of change with salt intake
Campbell, W.G. / Catanzaro, D.F. / Laragh, J.H. / Sealey, J.E. | 1999
97A-c
A004: Age and baseline blood pressure influence pressor effects of angiotensin II.
Sung, B.H. / Shah, K. / Kidambi, S. / Wilson, M.F. | 1999
98A
A005: Effects of angiotensin I and II and captopril on in vitro erythropoiesis.
Collart, F. / Corazza, F. / Hermans, C. / Wens, R. / Fondu, P. / Dratwa, M. | 1999
98A-a
A006: Mechanical strain increases collagen I mRNA expression in cultured human vascular smooth muscle cells via an angiotensin II-dependent pathway
Stanley, A.G. / Williams, B. | 1999
98A-b
A007: Effects of cholesterol on interaction of angiotensin II and insulin on dorsal hand vein.
Varga, C. / Sung, B.H. / Kidambi, S. / Shah, K. / Vallabhan, T. / Wilson, M.F. | 1999
98A-c
A008: Inhibitory effect of PD098059 on angiotensin II induced-mitogen activated protein kinase activation.
Zhu, S.J. / Chen, G.H. / Zhu, Z.M. / Hu, H.X. / Luo, X.D. | 1999
99A
A009: Baseline blood pressure predicts constrictor effects of angiotensin II on dorsal hand vein.
Sung, B.H. / Shah, K. / Kidambi, S. / Wilson, M.F. | 1999
99A-a
A010: Peculiarities of ischemic heart disease course in combination with essential hypertension.
Melnitsky, I.V. / Tashchuk, V.K. / Chaplinsky, R.B. / Polyanskaya, O.S. / Ilashchuk, I.I. | 1999
99A-b
A011: Angiotensin II induced greater venoconstriction in hypertensives
Vallabhan, T. / Sung, B.H. / Shah, K. / Kidambi, S. / Varadharajan, T. / Wilson, M.F. | 1999
99A-c
A012: Changes of lipid metabolism on condition of ischemic heart desease destabilization and essential hypertension.
Tashchuk, V.K. / Melnitsky, I.V. / Ilashchuk, I.I. | 1999
100A
A013: Renal vascular responses to captopril in healthy blacks: Vasodilation despite a high-salt intake.
Price, D.A. / Fisher, N.D.L. / Osei, S.Y. / Lansang, M.C. / Hollenberg, N.K. | 1999
100A-a
A014: Hypertensives exhibit enhanced pressor response to angiotensin II.
Sung, B.H. / Kidambi, S. / Vallabhan, T. / Shah, K. / Blum, R. / Wilson, M.F. | 1999
100A-b
A015: Arterial hypertension, myocardial infarction and obstructive pulmonary desease: Three-directed effect of irbesartan providing for optimum forming of postinfarction heart.
Vakalyuk, I.P. / Synoverska, O.B. / Byelogurov, P.L. | 1999
100A-c
A016: Irbesartan's influence on the forming of the connective cardiac matrix after myocardial infarction with hypertension.
Vakalyuk, I.P. / Byelogurov, P.L. / Nejko, E.M. / Seredyuk, N.M. | 1999
101A
A017: The association between polymorphism of renin-angiotensinogen genes and Chinese essential hypertensives
Wu, Kegui / Ye, Qiong / Zie, Liangdi | 1999
101A-a
A018: Central effects of AT1 receptor antagonism by eprosartan - in vitro autoradiography in the brain.
Muders, F. / Elsner, D. / Palkovits, M. / Riegger, GAJ. / Jandeleit, K. | 1999
102A
B001: Renal inducible NOS are responsible for the increased no synthesis in rats with high fructose diet.
Seculin, P. / Cosenzi, A. / Bernobich, E. / Plazzotta, N. / Bertola, G. / Galateo, C. / Bellini, G. | 1999
102A-a
B002: Role of enalapril (E) and diltiazem (DTZ) on tubulointerstitial lesions (TIL) in nephrotic rats (NR).
Toblli, J.E. / De Rosa, G. / Cao, G. / Angerosa, M. / Nyberg, C. | 1999
102A-b
B003: Angiotensin II-induced alterations in GTP-binding regulatory proteins in renal preglomerular arterioles from genetically hypertensive rats.
Vyas, S.J. / Blaschak, C.M. / Chinoy, M.R. / Jackson, E.K. | 1999
102A-c
B004: Role for glycation in the mecanism of renoprotection of calcium antagonist in Dahl salt hypertensive rat
Yamakado, M. / Taguchi, J. / Ohono, M. | 1999
103A
B005: Gonadal status and salt induced hypertension of the Sabra rat: Consequences in the distribution of renal {alpha}2-adrenoceptor subtypes
Ilhami, Norelyaqine / Khalid, Mostafa / Giudicelli, Yves / Dausse, Jean-Pierre | 1999
103A-a
B006: Hypertension in cafeteria fed rats: alteration in renal {alpha}2-adrenoceptor subtype
Coatmellec, G. / Ribière, C. / Giudicelli, Y. / Dausse, J.P. | 1999
103A-b
B007: A randomized and double blind comparison of isradipine, spirapril and their combination on decline in renal function in patients with chronic renal failure and hypertension.
Petersen, L.J. / Petersen, J.R. / Tallruphuus, U. / Møller, M.L. / Ladefoged, S.D. / Mehlsen, J. / Jensen, HÆ. | 1999
103A-c
B008: Renal perfusion in PTS with borderline hypertension (BH) based on Tc-DTPA transit renography.
Ivanov, M.V. | 1999
104A
B009: Renal perfusion determinants in PTS with borderline hypertension (BH).
Ivanov, M.V. | 1999
104A-a
B010: Serum uric acid (UA) and atherogenic lipides (AL) are nephrotoxic in PTS with essential hypertension (EH).
Ivanov, M.V. | 1999
104A-b
B011: Renal dopaminergic system participates in the natriuretic responses to acute sodium load in black salt-resistant but not in salt-sensitive subjects.
Damasceno, A. / Santos, A. / Pestana, M. / Serrão, P. / Soares-da-Silva, P. / Polónia, J. | 1999
104A-c
B012: Effects of fosinopril amlodipine combination on microalbuminuria in hypertensive patients with type 2 diabetes.
Zoppi, A. / Corradi, L. / Poletti, L. / Malamani, G.D. / Lazzari, P. / Preti, P. / Mugellini, A. / Pesce, R.M. / Fogari, R. | 1999
105A
B013: Comparable long-term renoprotection of amlodipine to ACE inhibitors in patients with moderate to severe renal dysfunction.
Kumagai, H. / Hayashi, K. / Kumamaru, H. / Saruta, T. | 1999
105A-a
B014: Comparison of prograf and neoral immunosuppression on plasma and urinary angiotensin peptides in adult kidney transplant recipients
Rohr, M.S. / Marterre, W.F. / Ferrario, C.M. / Yunis, C. / Brosnihan, K.B. | 1999
105A-b
B015: Apparent mineralocorticoid excess and pregnancy
Tedde, R. / Pala, A. / Lai, R. | 1999
105A-c
B016: Effects of treatment with ramipril on elderly patients with diabetes mellitus and albuminuria -
Zottola, C. / Mazzei, B. / Pranno, L. / Cundari, E. / Corsonello, A. / Gaudio, G. / Fiorentino, C. / Corsonello, F. | 1999
106A
B017: Quantitation of renal plasma flow with stage progress of essential hypertension using 99mTc-MAG3
Mukai, M. / Okuda, Y. / Konishi, S. / Takatsugi, K. / Matsuzaki, K. / Murakami, E. | 1999
107A
C001: Central blood pressure effects of S 23515, a ligand highly selective for imidazoline receptors over {alpha}2-adrenoceptors.
Bruban, V. / Feldman, J. / Jarry, C. / Schann, S. / Greney, H. / Scalbert, E. / Renard, P. / Dontenwill, M. / Bousquet, P. | 1999
107A-a
C002: Spinal nicotinic receptors in the SHR model of genetic hypertension
Khan, I. / Printz, M. / Taylor, P. | 1999
107A-b
C003: Autonomic stress responses in genetic hypertension: Role of specific brain regions.
Palmer, A.A. / Printz, M.P. | 1999
107A-c
C004: Effect of repeated restraint stress on baroreceptor reflex sensitivity: Role of corticotropin-releasing factor.
Conti, L.H. / Shannon, M.H. / Printz, M.P. | 1999
108A
C005: The release of acetylcholine and its dopaminergic regulation in the central nervous system of spontaneously hypertensive rats
Tsuda, K. / Kinoshita, Y. / Nishio, I. / Masuyama, Y. | 1999
108A-a
C006: Systolic and diastolic dysfunction in patients with diabetic autonomic neuropathy
Milovanovic, B. / Krotin, M. / Milovanovic, A. / Bisenic, V. / Zivanovic, B. / Vidric, D. / Veljovic, A. / Babic, M. | 1999
108A-b
C007: A major gender difference in the relation between adiposity and sympathetic activity in African-Americans.
Mansour, Y. / Abate, N. / Chavoshan, B. / Howell-Stampley, T. / Kizilbash, A. / Pollok, K. / Arbique, D. / Victor, R.G. | 1999
108A-c
C008: Effectiveness of propranolol in preventing vasovagal syncope in young men with primary hypertension
Di Girolamo, E. / Di Iorio, C. / Sabatini, P. / Leonzio, L. / Barsotti, A. | 1999
109A
C009: Peculiarities of heart rate reaction to passive head-up tilt and carotid baroreceptor reflex activation in patients with essential hypertension
Klincare, D. / Vitols, A. | 1999
109A-a
C010: Hyperthyroidism sinus tachycardia. Sympathetic stimulation or vagal inhibition?
Freitas, J. / Medina, J.L. / Santos, R.M. / Carvalho, M.J. / Costa, O. / Falcão de Freitas, A. | 1999
109A-b
C011: Changes in blood pressure and heart rate variability during dental surgery in essential hypertensives.
Miura, K. / Matsumura, K. / Nakamura, Y. / Kurokawa, H. / Yamashita, M. / Kajiyama, M. / Takata, Y. | 1999
109A-c
C012: Relationship between urinary catecholamines, ambulatory blood pressure, and microalbuminuria in hypertensive patients.
Gaudio, G. / Guasti, L. / Broggi, R. / Colombo, S. / Diolisi, A. / Garganico, D. / Grandi, A.M. / Bertolini, A. / Venco, A. | 1999
110A
C013: Heart rate and blood pressure variability in normotensive offspring of hypertensive subjects
Piccirillo, G. / Nocco, M. / Tarantini, S. / Lionetti, M. / Marigliano, V. | 1999
110A-a
C014: Hypertension and 1/f behavior of heart rate variability
Marcheselli, A. / Lino, S. / Strano, S. / Ferrucci, A. / Ciavarella, G.M. / Mazzei, A. / Calcagnini, G. | 1999
111A
D001: The antihypertensive effect of the berberine derivative 6-protoberberine in spontaneously hypertensive rats
Huang, Wein-Pin / Chan, Paul / Cheng, Juei-Tang | 1999
111A-a
D002: A double-blind placebo-controlled study of the effectiveness and safety of oral stevioside in human hypertension
Liu, Ju-Chi / Chan, Paul / Cheng, Juei-Tang | 1999
111A-b
D003: Bosentan reduces blood pressure and the renal damage induced by high fructose diet in rats
Cosenzi, A. / Bernobich, E. / Plazzotta, N. / Seculin, P. / Bonavita, M. / Costacurta, C. / Bellini, G. | 1999
111A-c
D004: Bosentan reduces the deposition of collagen III in the left ventricle of rats with hypertension induced by high fructose diet
Plazzotta, N. / Cosenzi, A. / Bernobich, E. / Seculin, P. / Bonavita, M. / Guidone, B. / Bellini, G. | 1999
112A
D005: Hemodynamic effects of quinapril in hypertension
Kumar, N. / McAlister, N.H. | 1999
112A-a
D006: In vivo blockade of angiotensin II receptor binding in rat kidney: comparison of candesartan cilexetil with losartan
Fabiani, M.E. / Dinh, D.T. / Nassis, L. / Johnston, C.I. | 1999
112A-b
D007: Effect of losartan on human platelet activation
Guerra, J.I. / Montón, M. / Rodriguez-Feo, J.A. / Jiménez, A.M. / González-Fernández, F. / Bellver, T. / Rico, L. / García, R. / Gómez, J. / Farré, J. et al. | 1999
112A-c
D008: Doxazosin modifies Bcl-2 and Bax protein expression in the left ventricle of spontaneously hypertensive rats
Rodríguez-Feo, J.A. / González-Fernández, F. / Guerra, J.I. / Jiménez, A. / Aceituno, E. / Arriero, M.M. / Ayala, R. / Farré, J. / García, R. / Rico, L. et al. | 1999
113A
D009: Eplerenone lessens blood pressure elevation in non-salt-loaded stroke-prone hypertensive rats
Stier, Charles T. / Chander, Praveen N. / Mullen, David / Lesnik, Gregory / Rocha, Ricardo | 1999
113A-a
D010: Effects of metformin on arterial vascular sympathetic nerve endings
Peuler, J.D. / Lee, J.M. | 1999
113A-b
D011: Isosorbide dinitrate spray (IDS) is better than isosorbide dinitrate tablets (IDT) in the treatment of hypertensive emergencies (HE)
Rubio G, A.F. / Vargas A, G. / Narvaez R, J.L. / Lozano N, J.J. / Rodriguez L, L. / Trejo O, N. / Castro S, D. | 1999
113A-c
D012: Effect of cicletanine and its sulfo-conjugated metabolite on thiazide-sensitive Na-Cl cotransporter function
Gamba, G. / Droy-Lefaix, M.T. / Garay, R.P. | 1999
114A
D013: Gender differences in venodilatory effect of diltiazem in healthy normotensive individuals
Iqbal, M. / Khan, Z. / Shah, K. / Babar, M. / Sung, B.H. | 1999
114A-a
D014: S-nitrosocaptopril crystals preferentially decreases diastalic pressure in hypertensive rats
Lin, Mo-jun / Yang, XP / Wang, J / Jia, BJ | 1999
114A-b
D015: Soft analogs of bufuralol: initial pharmacologic evaluation
Juhasz, A. / Hwang, S.K. / Yoon, S.H. / Tatrai-Prokai, K. / Bodor, N. | 1999
114A-c
D016: Effects of nifedipine on blood pressure in patients with essential hypertension
Wang, Xi-Feng | 1999
115A
D017: Good clinical practices in monitoring antihypertensive clinical trials
Jett, C.M. | 1999
115A-a
D018: The influence of hypertension and antihypertensive drugs on 'new' cardiovascular risk factors, in dyslipidaemic patients
Papadakis, J.A. / Jagroop, I.A. / Nair, D.R. / Ganotakis, E.S. / Mikhailidis, D.P. / Winder, A.F. | 1999
115A-b
D019: Therapeutic effects of irbesartan in left ventricular hypertrophy
Feraco, E. | 1999
115A-c
D020: Irbesartan as monotherapy in older hypertensives
Feraco, E. | 1999
116A
D021: Influence of long-term losartan monotherapy on regress of myocardial hypertrophy and left ventricular function in renal parenchymal arterial hypertension
Sirenko, Yu. / Granich, V. / Radchenko, A. / Reiko, M. / Sidorenko, P. | 1999
116A-a
D022: The effect of antihypertensive therapy with amlodipine on the morning catecholamines, angiotensin- converting enzyme and insulin increments
Mishchenko, L. / Svishchenko, E. / Yarinkina, L. / Mkhytarian, L. | 1999
116A-b
D023: Valsartan, high BP reduction and hypertensive drive in human essential hypertension
Fariello, Raffaele / Crippa, Massimo / Notaristefano, Ilaria / Costa, Raffaella / Chiari, Ermanna | 1999
116A-c
D024: Treatment of hypertension with valsartan (V) alone or combined with spironolactone (S)
Leone, A. / Bertanelli, F. / Mori, L. | 1999
117A
D025: Long-term effects of losartan on hypertension and left ventricular mass in elderly patients
Tedesco, M.A. / Ratti, G. / Mennella, S. / Rainone, A.C. / Grieco, M. / Iarussi, D. / Iacono, A. | 1999
117A-a
D026: Subjective sleep quality during two different antihypertensive medications: Isradipine vs metoprolol
Kantola, I.M. / Rauhala, E. / Partinen, M. / Polo, O. / Ekman, K. / Kataja, M. / FISH Study Group, | 1999
117A-b
D027: Effect of nifedipine on urinary protein excretion in hypertensive patients
Crippa, G. / Sverzellati, E. / Antoniotti, P. / Carrara, G.C. | 1999
117A-c
D028: Diuresis responds slowly to antihypertensive formulations of the loop diuretic torasemide
Reyes, A.J. / Leary, W.P. | 1999
118A
D029: Classification of thirty-three formulations of diuretics by natriuretic potency
Reyes, A.J. / Leary, W.P. | 1999
118A-a
D030: Evaluation over 1 year of a new therapeutic strategy of perindopril 2mg/indapamide 0.625mg in the treatment of essential hypertension in subjects over the age of 65 years
Castaigne, A. / Chalmers, J. / Chastang, C. / Feldmann, L. / Guez, D. | 1999
118A-b
D031: Lacidipine as a monotherapy in treatment of hypertension with concomitant ischemic heart disease
Chumburidze, V.B. / Kurashvili, R.B. / Kikalishvili, T.T. / Khidasheli, T.J. / Akhobadze, T.I. / Nacopia, N.R. / Khelashvili, M.G. | 1999
118A-c
D032: Effects of different dihydropyyridine calcium antagonists on plasma norepinephrine in essential hypertension.
Fogari, R. / Corradi, L. / Zoppi, A. / Mugellini, A. / Preti, P. / Malamani, G.D. / Mennoia, V.N. / Finardi, G. | 1999
119A
D033: Ace-inhibition but not angiotensin II antagonism improves fibrinolysis and insulin sensitivity in hypertensive post-menopausal women.
Preti, P. / Banderali, A. / Zoppi, A. / Corradi, L. / Mugellini, A. / Pesce, R.M. / Fogari, R. | 1999
119A-a
D034: Combination therapy of calcium antagonists and ace inhibitors--the incidence of vasodilatory edema
Messerli, F.H. / Feng, Z. / Gradman, A.H. | 1999
119A-b
D035: Postmarketing surveillance study of amlodipine in hypertensive patients with hypertension not controlled with other antihypertensive agents. (Preliminary results)
Gil, A. / Jiménez, R. / González, M. / San Martin, M. / Becerril, E. / Vega, A. / Espejo, J. | 1999
119A-c
D036: In vivo inhibition of angiotensin converting enzyme and neutral endopeptidase by a dual vasopeptidase inhibitor
Burrell, L.M. / Rockell, M.D. / Powell, J. / Johnston, C.I. | 1999
120A
D037: Influence of AT-1 receptor blockade on endothelium - derived factors in essential hypertension.
Cottone, S. / Vella, M.C. / Neri, A.L. / Vadalà, A. / Riccobene, R. / Cerasola, G. | 1999
120A-a
D038: Inhibition of sympathetic activity induced by losartan in essential hypertensives.
Cottone, S. / Neri, A.L. / Vella, M.C. / Vadalà, A. / Riccobene, R. / Cerasola, G. | 1999
120A-b
D039: Irbesartan safety and effectiveness: a post-marketing surveillance study
Bays, H.E. / Park, J.S. / Reilly, K. / Triscari, J. / AST investigators, | 1999
120A-c
D040: Long term efficacy, safety, and tolerability of candesartan cilexetil added to hydrochlorothiazide in patients with severe systemic hypertension
Oparil, Suzanne / Michelson, Eric L. / Candesartan Cilexetil Study Investigators, | 1999
121A
D041: Comparative effects of Candesartan Cilexetil and Losartan in systemic hypertension
Gradman, Alan H. / Michelson, Eric L. | 1999
121A-a
D042: Vasodilatory edema: synergistic effect of high-dose calcium antagonist/ace inhibitor combination therapy.
Messerli, F.H. / Feng, Z. / Michalewicz, L. | 1999
121A-b
D043: Raised aldosterone to renin ratio predicts anti-hypertensive efficacy of spironolactone. A prospective cohort follow-up study.
Lim, P.O. / Jung, R.T. / MacDonald, T.M. | 1999
121A-c
D044: Efficacy and tolerability of combination therapy in intensive blood pressure lowering - experience from the hot study.
Carruthers, George / Ruilope, Luis M. / HOT Study investigators, | 1999
122A
D046: Antihypertensive dose response of Omapatrilat, a vasopeptidase inhibitor, in mild to moderate hypertension
Weber, M.A. / Chang, P.I. / Reeves, R.A. / Moulton, K. / Pouleur, H. | 1999
122A-a
D047: Design and methods for the evaluation of Eprosartan in patients with isolated systolic hypertension
Black, H.R. / White, W.B. | 1999
122A-b
D048: Pediatric use of ace-inhibitors - a review from 1979 to 1996
Heintz, B. / Mertens, P. / Stefanidis, I. / Verho, M. | 1999
123A
D049: Effect of propranolol on muscle blood supply, energy metabolism, potassium ion balance and fatigue resistance at local static exercise in long-term antihypertensive treatment.
Vitols, A. / Liepina, D. | 1999
123A-a
D050: Characteristics of patients most likely to be treated in compliance with JNC-VI recommendations
Denton, Gerald D. / Smith, John / Faust, Joanne / Holmboe, Eric | 1999
123A-b
D051: Potential for use of pulse wave analysis in determining the interaction between Sildenafil and glyceryl trinitrate
O'Rourke, M. | 1999
123A-c
D052: Dose-response of the combination of irbesartan and hydrochlorothiazide in hypertensive patients.
Guthrie, R. / Weber, M. / Plat, F. | 1999
124A
D053: Lack of pharmacokinetic interaction between valsartan, an angiotensin II receptor blocker, and digoxin, a cardiotonic agent
Prasad, P. / Mangat, S. / Yeh, C.M. / Glazer, R. | 1999
124A-a
D054: Antihypertensive efficacy of Omapatrilat, a vasopeptidase inhibitor, compared with lisinopril.
Neutel, J. / Shepherd, A. / Pool, J. / Levy, E. / Saini, R. / Chang, P.I. | 1999
124A-b
D055: Safety and efficacy of nicardipine (NC) for hypertensive emergencies in children (CH)
Flynn, J.T. / Mottes, T.A. / Kershaw, D.B. / Smoyer, W.E. / Bunchman, T.E. | 1999
124A-c
D056: Amlodipine provides effective blood pressure (BP) control in children with primary or secondary hypertension (HTN)
Flynn, J.T. / Smoyer, W.E. / Bunchman, T.E. | 1999
125A
D057: How does the CA antagonist influence the relationship between blood pressure and physical activity by treating on short acting or long acting one?
Kakinoki, S. / Nomura, A. / Takechi, S. / Kitabatake, A. | 1999
125A-a
D058: Treatment of post-transplant erythrocytosis (PTE) with angiotensin-converting enzyme inhibitor (ACEi)
Pabico, R.C. / McKenna, B.A. / Yoo, K. / O'Mara, R. / Byer, B. / Yarger, J. / Kremer, M. / Monaghan, J. / Erturk, E. / Orloff, M. et al. | 1999
125A-b
D059: The safety and 24-hour antihypertensive efficacy of the vasopeptidase inhibitor Omapatrilat: a pilot study
Ruddy, M. / Guthrie, R. / Papademetriou, V. / Moulton, K. / Saini, R. | 1999
125A-c
D060: Efficacy and safety of Omapatrilat, a vasopeptidase inhibitor
Zusman, R. / Atlas, S. / Kochar, M. / Adler, E. / Levy, E. | 1999
126A
D061: Additional antihypertensive effect of fluvastatin in hypertensive and hypercholesterolemic patients treated with trandolapril
Pierdomenico, S.D. / Bucci, A. / Costantini, F. / Cipollone, F. / Cuccurullo, F. / Mezzetti, A. | 1999
126A-a
D062: Reduction in visual symptoms during antihypertensive monotherapies with long-acting calcium antagonists
Hernández-Hernández, R. / Armas-Hernández, M.J. / Velasco, M. / LASTLHY Steering Committee, | 1999
126A-b
D063: Efficacy and tolerability of the combination of Candesartan cilexetil and hydrochlorothiazide in systemic hypertension
Papademetriou, V. / Michelson, E.L. | 1999
126A-c
D064: Tolerability and antihypertensive efficacy of valsartan over 24 hours compared to nifedipine retard
Martínez, F. / Oigman, W. / Carrillo, J. Parra / Michieletto, L. / Valsartan Latam Investigators Group (VLIG), | 1999
127A
D065: Reduced diuretic-induced hypokalemia with valsartan in combination with HCTZ
Black, H. / Graff, A. / Glazer, R. / Shi, Y. | 1999
127A-a
D066: Superior tolerability of valsartan compared to captopril in asiatic patients
Lee, C.M. / Lee, Y.T. / Lang, M.G. / Prabowo, P. / Oddou-Stock, P. | 1999
127A-b
D067: Long-term efficacy and safety of valsartan in 823 mild to moderate hypertensives
Bremner, A. / Oddou-Stock, P. / Chrysant, S. / Marbury, T. / Feliciano, N. / Hester, A. / Cheng, H. | 1999
128A
D068: The antihypertensive efficacy and safety of Irbesartan compared with amlodipine for the treatment of mild-to-moderate hypertension.
Neutel, J. / Germino, W. / Smith, D. / Park, J-S. / Reilly, K. / Triscari, J. | 1999
128A-a
D070: Prognosis of elderly hypertensive patients in Japan
Hiwada, K. / Kohara, K. / Ogihara, T. / Matsumoto, M. / Matsuoka, H. / Shimamoto, K. / Takishita, S. / Toba, K. / Abe, I. | 1999
128A-b
D071: Antihypertensive drugs versus cardiovascular risk factors: the Zimbabwean experience
Ojewole, John A.O. / Kambarami, Runyararo M | 1999
129A
D072: Influence of the combination of verapamil and trandolapril on cardiovascular risk factors in patients with hypertension
Muñoz-Parra, F. / Gil-Extremera, B. / Maldonado-Martín, A. / Ruíz-López, M.F. / Huertas-Hernández, F. / León-Espinosa, M.T. / Ceballos-Atienza, R. / Cobo-Martínez, F. / Cruz-Benayas, M.A. / Castillo-Garzón, M.J. | 1999
129A-a
D073: Blood pressure and metabolic syndrome in essential hypertensive patients treated with losartan or verapamil after oral magnesium supplement.
Ruiz-López, M.F. / Gil-Extremera, B. / Maldonado-Martín, A. / Huertas-Hernández, F. / Ceballos-Atienza, R. / Muñoz-Parra, F. / Cruz-Benayas, M.A. / León-Espinosa-Monteros, M.T. / Cobo-Martínez, F. / Soto-Mas, J.A. | 1999
129A-b
D074: Let's stop using sublingual nifedipine now!
Ceballos-Atienza, R. / Extremera, B Gil / Martín, A Maldonado / Ruíz-López, M.F. / Huertas-Hernández, F. / Muñoz-Parra, F. / Cruz-Benayas, M.A. / Cano-Parra, M.D. / Martí-Canales, J.C. / Castillo-Garzón, M.J. | 1999
129A-c
D075: Objective monitoring of drug compliance: an important step in the management of hypertension resistant to drug therapy.
Burnier, M. / Schneider, M.P. / Chioléro, A. / Fallab, C.L. / Brunner, H.R. | 1999
130A
D076: Comparison of the angiotensin II receptor blockade induced by tasosartan and its active metabolite enoltasosartan in healthy subjects.
Rossat, J. / Maillard, M. / Brunner, H.R. / Burnier, M. | 1999
130A-a
D077: Evaluation of the interaction of tasosartan and enoltasosartan with plasma proteins using an angiotensin II receptor binding assay.
Maillard, M. / Rossat, J. / Centeno, C. / Brunner, H.R. / Burnier, M. | 1999
130A-b
D078: Improved short-term blood pressure control by treatment with calcium antagonists in patients with mild to moderate hypertension.
Lefrandt, J.D. / Urbigkeit, A. / Sevre, K. / Castellano, M. / Hausberg, M. / Fallon, M. / Fluckiger, L. / Heitmann, J. / Rostrup, M. / Rosei, E Agabiti et al. | 1999
130A-c
D079: Differential therapy by sectral and ednit in patients with arterial hypertension.
Binderis, N. / Kologrivova, L. / Mordovin, V. | 1999
131A
D080: Effects of ACE-inhibitors on the vegetative tone of the cardiovascular system in hypertensive patients
Konyaeva, E.B. / Agulova, L.P. / Kologrivova, L.V. / Mordovin, V.F. | 1999
131A-a
D081: Reduced heart rate during mental stress in hypertensive patients treated with verapamil compared to amlodipine.
Sevre, K. / Lefrandt, J.D. / Rostrup, M. / Smit, A.J. | 1999
131A-b
D082: Effects of valsartan on 24H ambulatory blood pressure monitoring
Ascioti, C. / Ferlaino, G. | 1999
131A-c
D083: Valsartan in the treatment of mild to moderate hypertension
Ascioti, C. / Ferlaino, G. | 1999
132A
D084: Lercanidipine in the treatment of mild to moderate hypertension.
Ascioti, C. / Ferlaino, G. | 1999
132A-a
D085: Treatment with doxazosin in hypertensive patients with dyslipidemia in Primary Care Centers.
Celorrio, J.M. / Jimenez, R. / Ansede, J.C. / Gil, A. | 1999
132A-b
D086: Beta blocker/HCTZ combination is superior to beta blocker alone in black patients with mild to moderate hypertension.
Radevski, I.V. / Valtchanova, Z.P. / Candy, G.P. / Tshele, E. / Sareli, P. | 1999
132A-c
D087: Quinapril/HCTZ combination rather than low-dose HCTZ should be recommended as first line antihypertensive therapy in black patients with mild to moderate hypertension.
Radevski, I.V. / Valtchanova, Z.P. / Candy, G.P. / Hopley, M. / Tshele, E. / Sareli, P. | 1999
133A
D088: Indapamide rather than low-dose HCTZ should be recommended as first line diuretic therapy in black patients with mild to moderate hypertension.
Radevski, I.V. / Valtchanova, Z.P. / Candy, G.P. / Tshele, E. / Ngcezula, T. / Sareli, P. | 1999
133A-a
D089: Differential effects of long acting ACE inhibitor and long acting calcium antagonist on ambulatory blood pressure in elderly hypertensive patients with different nocturnal BP fall
Eguchi, K. / Kario, K. / Shimada, K. | 1999
133A-b
D090: The effect of ACE inhibitors (A), {beta} blockers (B), Ca blockers (C) and diuretics (D) on untreated people with systolic hypertension
Morgan, T. / Anderson, A. / Lauri, J. / MacInnis, R. | 1999
133A-c
D091: Degree of diastolic blood pressure control among emergency department patients is not influenced by drug class of chronic antihypertensive medication.
Johns, C.D. / Geraci, S.A. / Schieginger, B. / Wesley, T.T. / Munir, A. / Blaho, K. | 1999
134A
D092: Indomethacin does not increase BP in hypertensive patients treated with amlodipine
Morgan, T. / Anderson, A. / Bertram, D. / Jones, E. | 1999
134A-a
D093: Beta blockers and serum potassium levels in hemodialysis patients.
Dunlay, R.W. / Frock, J.T. | 1999
134A-b
D094: The efficacy and safety of irbesartan in patients with essential hypertension in community hospitals of Catalonian
Felip, A. / Sobrino, J. / Plana, J. / Soler, J. / Ribera, L. / Adrián, M.J. / Módol, J. / Mínguez, A. / Esqué, J. / Pladevall, M. et al. | 1999
134A-c
D095: Use of Angiotensin (AII) antagonist losartan in patient treated with DSC LDL-apheresis.
Maxia, P. / Pintus, S. / Bianco, A. / Pintus, P. / Sanna, A. | 1999
135A
D096: A comparison of the inhibitory effects of candesartan cilexetil, losartan and valsartan on the response to angiotensin II infusion in hypertensive patients
Fridman, Katarina / Wysocki, Marian / Friberg, Peter / Andersson, Ove | 1999
135A-a
D097: Antihypertensive efficacy and safety of verapamil SR/trandolapril (240/2 mg) in patients insufficiently pretreated with verapamil SR 240 mg monotherapy.
Sever, P.S. / de Chatel, R. / Cifkova, R. / Sznajderman, M. / Notter, T. / Zilles, P. | 1999
135A-b
D098: Antihypertensive efficacy and effect on the left ventricular mass of losartan and trandolapril in patients with essential hypertension.
Valvo, E.V. / Stornello, M. / Canonico, G. / Di Pasquale, P. / Mossuti, E. | 1999
135A-c
D099: Enalapril versus valsartan at old patients: 24-hour antihypertensive efficacy and influence on quality of life
Nedogoda, S. / Chalabi, T. / Marchenko, I. / Butrina, L. / Sanina, T.N. / V, Petrov | 1999
136A
D100: Antioxidant action of moexipril in postmenopausal women with arterial hypertension
Nedogoda, S. / Buvailik, E. / Zhelezkin, V. | 1999
136A-a
D101: Which ACE inhibitor is better for postmenopausal women with high blood pressure?
Nedogoda, S. / Petrov, V. / Zhelezkin, V. | 1999
136A-b
D102: Efficacy and tolerability of amlodipine in elderly patients with hypertension.
Mazzei, B. / Zottola, C. / Fiorentino, C. / Pranno, L. / Cundari, E. / Corsonello, A. / Gaudio, G. / Corsonello, F. | 1999
136A-c
D103: Integrated cardiac and metabolic effects of the beta-1-selective blocker nebivolol in physically active patients with essential hypertension.
Mainka, W. / Schillings, W. / Scheele, K. / Duperly, J. / Ohba, H. / Fallois, J.V. / Schramm, T. / Rost, R.E. / Predel, H.G. | 1999
137A
D104: Effects of felodipine ER 10 mg and nitrendipine 20 mg on 24-hour blood pressure, stress tests and autonomic nervous system in hypertensive patients
Marcheselli, A. / Ferrucci, A. / Strano, S. / Ciavarel, G.M. / Lino, S. / Calcagnini, G. | 1999
137A-a
D105: Advantages of combined use of losartan and enalapril in patients with mild arterial hypertension
Koval, S.N. / Wilson, D.M. / Maslyaeva, L.V. / Penkova, M.Yu. / Bilovil, A.N. / Starchenko, T.G. | 1999
137A-b
D106: Diuretic therapy and renal cell carcinoma--what is the true risk/benefit ratio?
Messerli, F.H. / Grossman, E. / Goldbourt, U. | 1999
137A-c
D107: The additional efficacy of the diuretic-calcium antagonist combination depends on the potency of the drug introduced in first place.
Damasceno, A. / Caupers, P. / Santos, A. / Rafik, A. / Polónia, J. | 1999
138A
D108: Choice of antihypertensive medications for black female patients by physician specialty and region
Leader, S. / Muhuri, P. | 1999
138A-a
D109: Coronary events in diabetic and non-diabetic subjects on calcium channel antagonists or other antihypertensive drugs.
Boumendil, E.F. / Mugnier, C. | 1999
138A-b
D110: Perindopril in elderly hypertensives
Grandinetti, O. / Muti, V. / Matrangolo, E. / De Marco, A. / Ortale, C. / Chiappetta, P. / Monizzi, D. / Mirabelli, F. / Cherchi, M. | 1999
138A-c
D111: Combination EDNYT and COZAAR in heart failure with metabolic syndrome X.
Orynchak, MA / Neiko, EM / Seredjuk, VN / Seredjuk, NM | 1999
139A
E001: Metformin as an option for the management of obese patients with stage 1 hypertension.
Rubio, A.F. / Vargas, G. / Rodriguez, L. / Lozano, J.J. / Ramos, L. / Montaño, R. / Granados, M. | 1999
139A-a
E002: Irbesartan and atorvastatin improves endothelial function in hypertensive and hypercholesterolemic men
Calvo, C. / Gude, F. / Mosquera, A. / Riveiro, A. / Paz, E. / Pérez-Leirós, P. | 1999
139A-b
E003: Efficacy over 1 year of a fixed low-dose combination of perindopril 2 mg/indapamide 0.625 mg in the treatment of isolated systolic hypertension in subjects aged over 65 years
Chalmers, J. / Castaigne, A. / Chastang, C. / Feldmann, L. / Guez, D. | 1999
139A-c
E004: In hypertensive women, candesartan cilexetil lowers blood pressure more effectively and is better tolerated than enalapril or a diuretic.
Malmqvist, K. | 1999
140A
E005: Usefulness of the loaned self-measurement equipment model for diagnosis and treatment adjustment during a clinical trial using valsartan
Calvo-Vargas, C.G. / Galarza, D. / García-Gutiérrez, C. / Asociación de Medicina Interna de México research group., | 1999
140A-a
E006: The efficacy and safety of zofenopril compared to amlodipine in patients with mild to moderate hypertension
Giusti, A. / Bertolotti, M. / Clark, W.I.C. / Harrison, F.J.J. / de la Motte, S. / Casini, A. | 1999
140A-b
E007: Losartan treatment of patients with isolated systolic hypertension.
Farsang, C. / Garcia-Puig, J. / Niegowska, J. / Quintero Baiz, A. / Vrijens, F. / Bortman, G. / Losartan ISH Trial Investigators Group, | 1999
140A-c
E008: Safety of adenosine pharmacologic stress testing in subjects with low systolic arterial pressure
Haji, S.A. / Alkoutami, G.S. / Movahed, A. | 1999
141A
E009: Baseline characteristics of the first 14,242 patients enrolled in the convince study.
Black, H.R. / Elliott, W.J. / Grandits, G. / Fakouhi, T.D. / CONVINCE Study Group, | 1999
141A-a
E010: ABCD-2V: Appropriate blood pressure control in diabetes--part 2 with valsartan
Schrier, R.W. / Estacio, R.O. / Jeffers, B.W. / Biggerstaff, S. / Krinsky, E. / Pincus, J.R. / Bedigian, M.P. | 1999
141A-b
E011: History of hypertension and causes of death after acute myocardial infarction.
Berton, G. / Cordiano, R. / Mormino, P. / Mbaso, S. / Pianca, S. / Guarnieri, G.L. / Pagliara, V. / Piccoli, G. / Cucchini, F. / Palatini, P. | 1999
141A-c
E012: Improvement in cognitive function during antihypertensive monopharmacotherapy with calcium antagonists
Alcocer, L. / Armas-Hernández, M.J. / Hernández-Hernández, R. / LASTLHY Steering Committee, | 1999
142A
E013: Non-dipping of blood pressure during sleep does not predict awake or exercise hemodynamics. The Zilot study.
Papademetriou, V. / Narayan, P. / Kokkinos, P. / Neutel, J. | 1999
142A-a
E014: One year of antihypertensive treatment in patients with LVH: The life study.
Kjeldsen, S.E. / Dahlöf, B. / Devereux, R.B. / Julius, S. / Beevers, G. / Faire, U. / Fyhrquist, F. / Ibsen, H. / Kristianson, K. / Pedersen, O.L. et al. | 1999
142A-b
E015: The value trial: Patients demographics and progress report.
Julius, S. / Brunner, H.R. / Hansson, L. / Heath, R. / Kjeldsen, S.E. / Laragh, J.H. / McInnes, G.T. / Weber, M.A. / Zanchetti, A. / VALUE Study Group, | 1999
142A-c
E016: Effects on ambulatory blood pressure of low-dose aspirin in treated hypertensive patients.
Palumbo, G. / Alli, C. / Avanzini, F. / Bertele', V. / Colombo, F. / Pangrazzi, I. / Roncaglioni, C. / Tognoni, G. / PPP-Hypertension Study Investigators, | 1999
143A
E017: Effects of vitamin E on ambulatory blood pressure in hypertensive patients.
Palumbo, G. / Alli, C. / Avanzini, F. / Bertele', V. / Colombo, F. / Pangrazzi, I. / Roncaglioni, C. / Tognoni, G. / PPP-Hypertension Study Investigators, | 1999

Ähnliche Titel